| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 RAPGEF6 SIPA1L3 RCBTB2 SYNGAP1 SIRPG ARHGAP31 DOCK1 ARHGEF28 GOPC RASA2 PSD3 RAB3GAP1 RGS18 KNDC1 AKAP13 MTSS2 | 5.60e-05 | 507 | 222 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 RAPGEF6 SIPA1L3 RCBTB2 SYNGAP1 SIRPG ARHGAP31 DOCK1 ARHGEF28 GOPC RASA2 PSD3 RAB3GAP1 RGS18 KNDC1 AKAP13 MTSS2 | 5.60e-05 | 507 | 222 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.24e-04 | 44 | 222 | 5 | GO:0140938 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 2.77e-04 | 12 | 222 | 3 | GO:0043121 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 CDHR2 CDH23 PTPRF PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TENM3 | 2.05e-10 | 187 | 222 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA9 CDHR2 CDH23 MAGI2 PTPRF PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 SLITRK3 PCDHA3 PCDHA2 PCDHA1 TENM3 | 9.07e-09 | 313 | 222 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | ARHGAP32 AHI1 ATP7A ABL2 MAP1B ZMYND8 MAGI2 TTBK2 PTPRF NGFR NTRK2 NTRK3 TENM3 SCARB2 PLXNA4 PALM MAP3K13 AGRN | 7.25e-06 | 494 | 222 | 18 | GO:0031346 |
| GeneOntologyBiologicalProcess | cell junction organization | ABL2 MAP1B ZMYND8 MPDZ NFASC ITGB4 SYNGAP1 MAGI2 DST PTPRF DOCK1 ANK2 NTRK2 NTRK3 UBE3B SLITRK3 GRIN2A SPTBN4 LRRN3 TENM3 SNAI2 PLXNA4 PALM KIRREL1 AGRN DMTN | 1.91e-05 | 974 | 222 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 ATP7A ABL2 MAP1B CDH23 NFASC SYNGAP1 DST PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 KNDC1 MAP3K13 AGRN | 2.05e-05 | 748 | 222 | 22 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ARHGAP32 ATP7A ABL2 MAP1B SIPA1L3 DACT2 CDH23 NFASC BAP1 SYNGAP1 DST PTPRF NGFR BRWD1 ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S FRMD6 PLXNA4 KNDC1 PALM MAP3K13 AGRN DMTN | 3.52e-05 | 1194 | 222 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection development | ARHGAP32 AHI1 ATP7A ABL2 MAP1B ZMYND8 CDH23 MPDZ NFASC SYNGAP1 MAGI2 DST ALMS1 PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S TENM3 SCARB2 PLXNA4 KNDC1 PALM MAP3K13 AGRN | 5.28e-05 | 1285 | 222 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | clustering of voltage-gated sodium channels | 6.62e-05 | 8 | 222 | 3 | GO:0045162 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP32 ABL2 SIPA1L3 SYNGAP1 ARHGAP31 NGFR RIPOR1 ARHGEF28 RASA2 PSD3 GRIN2A AKAP13 AGRN | 6.97e-05 | 333 | 222 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | ARHGAP32 AHI1 ATP7A ABL2 MAP1B CDHR2 ZMYND8 SYNGAP1 MAGI2 TTBK2 PTPRF NGFR NTRK2 NTRK3 TENM3 SCARB2 PLXNA4 KNDC1 PALM MAP3K13 AGRN DMTN | 1.26e-04 | 846 | 222 | 22 | GO:0120035 |
| GeneOntologyBiologicalProcess | axonogenesis | ARHGAP32 MAP1B NFASC SYNGAP1 DST NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 MAP3K13 AGRN | 1.44e-04 | 566 | 222 | 17 | GO:0007409 |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 1.47e-04 | 47 | 222 | 5 | GO:0038179 | |
| GeneOntologyBiologicalProcess | postsynapse organization | ABL2 MAP1B ZMYND8 SYNGAP1 MAGI2 PTPRF DOCK1 NTRK3 UBE3B SLITRK3 GRIN2A AGRN | 1.57e-04 | 313 | 222 | 12 | GO:0099173 |
| GeneOntologyBiologicalProcess | synapse organization | ABL2 MAP1B ZMYND8 NFASC SYNGAP1 MAGI2 PTPRF DOCK1 NTRK2 NTRK3 UBE3B SLITRK3 GRIN2A SPTBN4 LRRN3 TENM3 PLXNA4 PALM AGRN | 1.64e-04 | 685 | 222 | 19 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 ATP7A ABL2 MAP1B NFASC SYNGAP1 DST PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 KNDC1 MAP3K13 AGRN | 1.64e-04 | 802 | 222 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ARHGAP32 AHI1 ATP7A ABL2 MAP1B CDHR2 ZMYND8 SYNGAP1 MAGI2 TTBK2 PTPRF NGFR NTRK2 NTRK3 TENM3 SCARB2 PLXNA4 KNDC1 PALM MAP3K13 AGRN DMTN | 1.67e-04 | 863 | 222 | 22 | GO:0031344 |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.70e-04 | 144 | 222 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.79e-04 | 145 | 222 | 8 | GO:0001578 | |
| GeneOntologyBiologicalProcess | retinal rod cell differentiation | 1.89e-04 | 27 | 222 | 4 | GO:0060221 | |
| GeneOntologyBiologicalProcess | axon development | ARHGAP32 MAP1B NFASC SYNGAP1 DST PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 MAP3K13 AGRN | 2.15e-04 | 642 | 222 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGAP32 ATP7A ABL2 MAP1B NFASC SYNGAP1 DST PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 KNDC1 MAP3K13 AGRN | 2.19e-04 | 819 | 222 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 ATP7A ABL2 MAP1B NFASC SYNGAP1 DST PTPRF NGFR ARHGEF28 NTRK2 NTRK3 LMTK2 SIAH1 SLITRK3 SPTBN4 MAP1S PLXNA4 KNDC1 MAP3K13 AGRN | 2.45e-04 | 826 | 222 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGAP32 RAPGEF6 ABL2 SIPA1L3 SYNGAP1 ARHGAP31 NGFR RIPOR1 DOCK1 ARHGEF28 RASA2 PSD3 GRIN2A KNDC1 AKAP13 AGRN | 2.52e-04 | 538 | 222 | 16 | GO:0007264 |
| GeneOntologyBiologicalProcess | dendrite development | ATP7A ABL2 MAP1B ZMYND8 MPDZ SYNGAP1 PTPRF NGFR NTRK2 MAP1S KNDC1 PALM | 2.92e-04 | 335 | 222 | 12 | GO:0016358 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP1B ZNF207 NCKAP5 TTBK2 DST ALMS1 BRCA2 STARD9 NAV1 CCDC187 TACC2 SETD2 MAP1S FMN2 CFAP74 CEP152 AGRN HYDIN CFAP46 | 3.07e-04 | 720 | 222 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | ARHGAP32 AHI1 ATP7A ABL2 MAP1B ZMYND8 ZNF205 FYCO1 DELE1 SIRPG MAGI2 TTBK2 ALMS1 PTPRF NGFR SGO2 NTRK2 NTRK3 RICTOR SLITRK3 RAB3GAP1 LRRN3 TENM3 SCARB2 PLXNA4 PALM KIRREL1 MAP3K13 AGRN | 3.58e-04 | 1366 | 222 | 29 | GO:0051130 |
| GeneOntologyCellularComponent | asymmetric synapse | ARHGAP32 ATP7A MAP1B MPDZ SYNGAP1 MAGI2 DST PTPRF NGFR CACNA1C ANK2 GOPC NTRK2 PSD3 SLITRK3 GRIN2A PLXNA4 PALM DMTN | 1.10e-06 | 477 | 225 | 19 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | ARHGAP32 ATP7A MAP1B MPDZ SYNGAP1 MAGI2 DST PTPRF NGFR CACNA1C ANK2 GOPC NTRK2 PSD3 SLITRK3 GRIN2A PALM DMTN | 2.06e-06 | 451 | 225 | 18 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARHGAP32 ATP7A MAP1B MPDZ SYNGAP1 MAGI2 DST PTPRF NGFR CACNA1C ANK2 GOPC NTRK2 PSD3 SLITRK3 GRIN2A PLXNA4 PALM DMTN | 4.21e-06 | 523 | 225 | 19 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic specialization | ARHGAP32 ATP7A MAP1B MPDZ SYNGAP1 MAGI2 DST PTPRF NGFR CACNA1C ANK2 GOPC NTRK2 PSD3 SLITRK3 GRIN2A PALM DMTN | 9.32e-06 | 503 | 225 | 18 | GO:0099572 |
| GeneOntologyCellularComponent | postsynapse | ARHGAP32 ATP7A ABL2 MAP1B ZMYND8 MPDZ ITGB4 CHRNA5 SYNGAP1 MAGI2 DST PTPRF NGFR DOCK1 CACNA1C ANK2 GOPC NTRK2 NTRK3 UBE3B PSD3 SLITRK3 GRIN2A RAB3GAP1 PALM DMTN SENP7 | 1.48e-05 | 1018 | 225 | 27 | GO:0098794 |
| GeneOntologyCellularComponent | ciliary base | 3.38e-04 | 56 | 225 | 5 | GO:0097546 | |
| GeneOntologyCellularComponent | ciliary inversin compartment | 6.82e-04 | 4 | 225 | 2 | GO:0097543 | |
| GeneOntologyCellularComponent | PR-DUB complex | 6.82e-04 | 4 | 225 | 2 | GO:0035517 | |
| HumanPheno | Abnormal calvaria morphology | AHI1 ATP7A SETD1B MAP1B CWC27 MPDZ NFASC PIGG ITGB4 CASZ1 FREM1 PHF21A BAP1 SYNGAP1 KMT2C ALMS1 BRCA2 ARHGAP31 MED12 CACNA1C FLT4 TCF20 RASA2 NSD2 NTRK2 UBE3B SETD2 RAB3GAP1 NPHP3 KANSL1 AASS ASXL3 SETBP1 SNAI2 CEP152 SPEN | 1.21e-05 | 1254 | 76 | 36 | HP:0002683 |
| HumanPheno | Abnormality of the outer ear | AHI1 MAP1B CWC27 MPDZ PIGG ITGB4 NEK9 CASZ1 FREM1 BAP1 SYNGAP1 KMT2C DST ALMS1 PTPRF BRCA2 MED12 CACNA1C FLT4 TCF20 RASA2 NSD2 UBE3B SIAH1 RAB3GAP1 NPHP3 KANSL1 TENM3 AASS ASXL3 SETBP1 CEP152 EXOC2 SRRM2 SPEN AGRN | 5.46e-05 | 1337 | 76 | 36 | HP:0000356 |
| HumanPheno | Aplasia/Hypoplasia affecting the fundus | AHI1 CWC27 CDH23 MPDZ PIGG MDH2 CASZ1 SYNGAP1 ALMS1 SARDH MED12 IMPG2 CACNA1C NSD2 NTRK2 UBE3B SETD2 RAB3GAP1 NPHP3 KANSL1 TRAPPC12 AASS VCAN CFAP74 EXOC2 SPEN HYDIN INVS MTSS2 | 6.43e-05 | 965 | 76 | 29 | HP:0008057 |
| HumanPheno | Aplasia/Hypoplasia affecting the eye | AHI1 CWC27 CDH23 MPDZ PIGG MDH2 CASZ1 FREM1 SYNGAP1 ALMS1 BRCA2 ARHGAP31 SARDH MED12 IMPG2 CACNA1C NSD2 NTRK2 UBE3B SETD2 RAB3GAP1 NPHP3 KANSL1 TENM3 TRAPPC12 AASS VCAN CFAP74 EXOC2 SPEN HYDIN INVS MTSS2 | 6.94e-05 | 1183 | 76 | 33 | HP:0008056 |
| HumanPheno | Abnormality of calvarial morphology | AHI1 ATP7A SETD1B CWC27 MPDZ PIGG ITGB4 CASZ1 FREM1 PHF21A BAP1 SYNGAP1 KMT2C BRCA2 ARHGAP31 MED12 CACNA1C FLT4 TCF20 RASA2 NSD2 NTRK2 UBE3B SETD2 RAB3GAP1 NPHP3 KANSL1 AASS ASXL3 SETBP1 CEP152 SPEN | 7.68e-05 | 1134 | 76 | 32 | HP:0002648 |
| HumanPheno | Autistic behavior | SETD1B MAP1B PIGG MDH2 CASZ1 PHF21A BAP1 SYNGAP1 KMT2C ALMS1 MED12 CACNA1C TCF20 NSD2 NTRK2 GRIN2A SETD2 KANSL1 ASXL3 SETBP1 SRRM2 SPEN MTSS2 | 8.20e-05 | 678 | 76 | 23 | HP:0000729 |
| HumanPheno | Downslanted palpebral fissures | ATP7A SETD1B CWC27 MPDZ PIGG NEK9 FREM1 BAP1 SYNGAP1 MED12 RASA2 NSD2 NTRK2 SIAH1 SETD2 ASXL3 SETBP1 CEP152 SPEN | 8.50e-05 | 497 | 76 | 19 | HP:0000494 |
| HumanPheno | Slanting of the palpebral fissure | ATP7A SETD1B CWC27 MPDZ PIGG NEK9 FREM1 BAP1 SYNGAP1 BRCA2 MED12 RASA2 NSD2 NTRK2 UBE3B SIAH1 SETD2 KANSL1 ASXL3 SETBP1 CEP152 EXOC2 SPEN MTSS2 | 1.10e-04 | 739 | 76 | 24 | HP:0200006 |
| HumanPheno | Abnormal location of ears | AHI1 MAP1B CWC27 MPDZ PIGG NEK9 CASZ1 FREM1 BAP1 SYNGAP1 DST MED12 CACNA1C TCF20 RASA2 NSD2 UBE3B SIAH1 RAB3GAP1 KANSL1 TENM3 ASXL3 SETBP1 CEP152 EXOC2 SRRM2 SPEN AGRN | 1.20e-04 | 945 | 76 | 28 | HP:0000357 |
| HumanPheno | Diagnostic behavioral phenotype | SETD1B MAP1B CDH23 PIGG MDH2 CASZ1 PHF21A BAP1 SYNGAP1 KMT2C ALMS1 MED12 CACNA1C TCF20 NSD2 NTRK2 GRIN2A SETD2 KANSL1 ASXL3 SETBP1 SRRM2 SPEN MTSS2 | 1.30e-04 | 747 | 76 | 24 | HP:0025783 |
| HumanPheno | Abnormal facial shape | AHI1 ATP7A SETD1B CWC27 CDH23 MPDZ PIGG PHF21A BAP1 SYNGAP1 KMT2C ALMS1 BRCA2 MED12 CACNA1C FLT4 TCF20 RASA2 NSD2 NTRK2 UBE3B GRIN2A SETD2 RAB3GAP1 NPHP3 KANSL1 AASS ASXL3 SETBP1 CEP152 EXOC2 SPEN AGRN | 1.34e-04 | 1221 | 76 | 33 | HP:0001999 |
| Domain | Cadherin_tail | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.88e-15 | 37 | 223 | 12 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.88e-15 | 37 | 223 | 12 | IPR031904 |
| Domain | Cadherin | PCDHA9 CDHR2 CDH23 FREM1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FREM3 | 7.90e-13 | 118 | 223 | 16 | IPR002126 |
| Domain | Cadherin_2 | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.44e-11 | 65 | 223 | 12 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.44e-11 | 65 | 223 | 12 | IPR013164 |
| Domain | Cadherin_CS | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.68e-11 | 109 | 223 | 14 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.68e-11 | 113 | 223 | 14 | PS00232 |
| Domain | Cadherin | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.68e-11 | 113 | 223 | 14 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.67e-11 | 114 | 223 | 14 | PS50268 |
| Domain | - | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.67e-11 | 114 | 223 | 14 | 2.60.40.60 |
| Domain | CA | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.77e-11 | 115 | 223 | 14 | SM00112 |
| Domain | Cadherin-like | PCDHA9 CDHR2 CDH23 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.10e-10 | 116 | 223 | 14 | IPR015919 |
| Domain | Post-SET_dom | 3.22e-05 | 16 | 223 | 4 | IPR003616 | |
| Domain | PostSET | 3.22e-05 | 16 | 223 | 4 | SM00508 | |
| Domain | POST_SET | 3.22e-05 | 16 | 223 | 4 | PS50868 | |
| Domain | Calx_beta | 1.34e-04 | 9 | 223 | 3 | IPR003644 | |
| Domain | Calx-beta | 1.34e-04 | 9 | 223 | 3 | PF03160 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.58e-04 | 11 | 223 | 3 | IPR002011 | |
| Domain | Ig-like_fold | VSIG2 INSRR NFASC CMYA5 ITGB4 CRLF2 SIRPG PTPRF ADGRF5 FLT4 NTRK2 NTRK3 MPZL1 LRRN3 IGHA2 VCAN PLXNA4 KIRREL1 EXOC2 BTNL9 | 3.24e-04 | 706 | 223 | 20 | IPR013783 |
| Domain | RECEPTOR_TYR_KIN_II | 3.41e-04 | 12 | 223 | 3 | PS00239 | |
| Domain | - | VSIG2 INSRR NFASC CMYA5 ITGB4 CRLF2 SIRPG PTPRF ADGRF5 FLT4 NTRK2 NTRK3 MPZL1 LRRN3 VCAN PLXNA4 KIRREL1 EXOC2 BTNL9 | 3.97e-04 | 663 | 223 | 19 | 2.60.40.10 |
| Domain | TPKR_C2 | 4.22e-04 | 3 | 223 | 2 | PF16920 | |
| Domain | MAP1 | 4.22e-04 | 3 | 223 | 2 | IPR026074 | |
| Domain | Tyr_kinase_NGF_rcpt | 4.22e-04 | 3 | 223 | 2 | IPR020777 | |
| Domain | NTRK_C2 | 4.22e-04 | 3 | 223 | 2 | IPR031635 | |
| Domain | Ig_I-set | 4.77e-04 | 190 | 223 | 9 | IPR013098 | |
| Domain | I-set | 4.77e-04 | 190 | 223 | 9 | PF07679 | |
| Domain | SEA | 5.55e-04 | 14 | 223 | 3 | SM00200 | |
| Domain | - | 6.87e-04 | 15 | 223 | 3 | 3.30.70.960 | |
| Domain | AT_hook | 8.38e-04 | 16 | 223 | 3 | PF02178 | |
| Domain | Pkinase_Tyr | 9.18e-04 | 129 | 223 | 7 | PF07714 | |
| Domain | ZF_PHD_2 | 9.73e-04 | 95 | 223 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.03e-03 | 96 | 223 | 6 | PS01359 | |
| Domain | PROTEIN_KINASE_TYR | 1.08e-03 | 97 | 223 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.08e-03 | 97 | 223 | 6 | IPR008266 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.36e-03 | 138 | 223 | 7 | IPR001245 | |
| Domain | AWS | 1.39e-03 | 5 | 223 | 2 | SM00570 | |
| Domain | AWS | 1.39e-03 | 5 | 223 | 2 | PS51215 | |
| Domain | AWS_dom | 1.39e-03 | 5 | 223 | 2 | IPR006560 | |
| Domain | YD | 1.39e-03 | 5 | 223 | 2 | IPR006530 | |
| Domain | SET | 1.42e-03 | 41 | 223 | 4 | PF00856 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.22e-24 | 15 | 229 | 12 | 15640798 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.98e-23 | 17 | 229 | 12 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.90e-23 | 18 | 229 | 12 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 8.90e-23 | 18 | 229 | 12 | 10662547 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.25e-20 | 24 | 229 | 12 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.38e-19 | 28 | 229 | 12 | 15347688 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 | 1.08e-18 | 11 | 229 | 9 | 9655502 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 RAPGEF6 HIVEP1 ABL2 MAP1B SIPA1L3 MPDZ PSMD7 NEK9 CEP170 USP31 DST ALMS1 CASKIN2 STARD9 NAV1 ARHGEF28 TCF20 NELFCD NTRK3 PSD3 LMTK2 RICTOR RAB11FIP1 MTMR4 FRMD6 AASS FMN2 AKAP13 CEP152 CRYBG3 SRRM2 DMTN MTSS2 | 5.85e-17 | 861 | 229 | 34 | 36931259 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.71e-15 | 57 | 229 | 12 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.39e-15 | 58 | 229 | 12 | 30377227 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.62e-14 | 68 | 229 | 12 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.39e-14 | 72 | 229 | 12 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.61e-14 | 74 | 229 | 12 | 10817752 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.01e-14 | 75 | 229 | 12 | 15372022 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.25e-13 | 77 | 229 | 12 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.02e-13 | 80 | 229 | 12 | 10716726 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 3.77e-13 | 12 | 229 | 7 | 10612399 | |
| Pubmed | PCDHA9 ABL2 NFASC NCKAP5 MEPE BRCA2 DOCK1 ANK2 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA3 PCDHA2 PCDHA1 TGOLN2 SPEN | 9.03e-13 | 329 | 229 | 19 | 17474147 | |
| Pubmed | NR2C2 RAPGEF6 HIVEP1 ZGRF1 ZMYND8 NEK9 PHF21A BAP1 DST ALMS1 BRCA2 NAV1 MED12 TBL1X TCF20 NELFCD ATG2B RLF TMF1 CRYBG3 | 6.97e-12 | 418 | 229 | 20 | 34709266 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.54e-11 | 119 | 229 | 12 | 28625976 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 SETD1B SIPA1L3 FYCO1 PIGG BCL9 ITGB4 CASZ1 BAP1 KMT2C DST PTPRF NAV1 RIPOR1 MICAL3 MED12 WDR24 NSD2 UBE3B LMTK2 KTI12 TEP1 KANSL1 MAP1S TRAPPC12 PALM PCNX1 AKAP13 SPEN AGRN | 6.00e-11 | 1105 | 229 | 30 | 35748872 |
| Pubmed | ARHGAP32 RAPGEF6 ATP7A ABL2 USP31 DST MICAL3 FAM135A TOR1AIP2 GOPC MPZL1 PSD3 RICTOR RAB11FIP1 TENM3 PALM KIRREL1 MTSS2 | 4.97e-10 | 421 | 229 | 18 | 36976175 | |
| Pubmed | PCDHA9 MYCBPAP PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.99e-10 | 193 | 229 | 13 | 22589738 | |
| Pubmed | ARHGAP32 SIPA1L3 TTC14 DELE1 NEK9 CASZ1 CEP170 ALMS1 ADGRF5 MICAL3 FAM135A MED12 ARHGEF28 RICTOR SETD2 RAB3GAP1 NPHP3 CEP152 | 5.94e-09 | 493 | 229 | 18 | 15368895 | |
| Pubmed | ARHGAP32 SIPA1L3 PSMD7 USP31 PTPRF CASKIN2 MICAL3 TOR1AIP2 RELCH GOPC NSD2 TPTE2 MPZL1 PSD3 LMTK2 RICTOR IDE RAB11FIP1 IWS1 MTMR4 TMF1 FMN2 PALM KIRREL1 CRYBG3 SRRM2 | 8.20e-09 | 1049 | 229 | 26 | 27880917 | |
| Pubmed | 9.11e-09 | 5 | 229 | 4 | 34888534 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 RAPGEF6 HIVEP1 ARID4B ZMYND8 BCL9 BAP1 RIPOR1 MICAL3 TCF20 RBBP6 RICTOR WTAP IWS1 SETD2 KANSL1 MAP1S MDC1 EXOC2 SRRM2 SPEN LRRFIP1 | 1.13e-08 | 774 | 229 | 22 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NR2C2 HIVEP1 ARID4B BCL9 PHF21A KMT2C ALMS1 MED12 TBL1X TCF20 RBBP5 RLF ASXL3 MDC1 SPEN | 1.45e-08 | 351 | 229 | 15 | 38297188 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HIVEP1 CWC27 SIPA1L3 CDH23 CEP170 WDR24 RBBP6 RLF SPTBN4 MAP1S ASXL3 MDC1 AKAP13 SRRM2 SPEN | 2.11e-08 | 361 | 229 | 15 | 26167880 |
| Pubmed | ZHX3 NR2C2 HIVEP1 ZMYND8 BCL9 CASZ1 PHF21A BAP1 MED12 TBL1X TCF20 RBBP5 MDC1 | 3.12e-08 | 268 | 229 | 13 | 33640491 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 RAPGEF6 ZMYND8 BCL9 NEK9 SYNGAP1 ARHGAP31 DOCK1 RBBP6 WTAP MAP1S MDC1 SETBP1 AKAP13 SPEN LRRFIP1 | 3.28e-08 | 430 | 229 | 16 | 35044719 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 PTPRF CASKIN2 ARHGAP31 NAV1 MICAL3 FAM135A RELCH ANK2 GOPC MPZL1 PSD3 RICTOR SLITRK3 RAB11FIP1 FMN2 PALM KIRREL1 | 5.27e-08 | 569 | 229 | 18 | 30639242 |
| Pubmed | FBXO40 HIVEP1 NEK9 CASZ1 LPIN1 KMT2C DST ALMS1 STARD9 TCF20 PERM1 SRRM2 | 5.55e-08 | 233 | 229 | 12 | 37704626 | |
| Pubmed | ARID4B MAP1B ECD PSMD7 NEK9 CEP170 DST ALMS1 NAV1 SGO2 MICAL3 MED12 NSD2 ATG2B WTAP IWS1 RLF CEP152 SPEN | 6.77e-08 | 645 | 229 | 19 | 25281560 | |
| Pubmed | ABL2 MAP1B SYNGAP1 MAGI2 DST MICAL3 CACNA1C ANK2 HSPA4L GRIN2A FMN2 PALM SRRM2 DMTN | 9.04e-08 | 347 | 229 | 14 | 17114649 | |
| Pubmed | SUSD6 NFASC PHF21A BAP1 KMT2C DST CASKIN2 ARHGAP31 RELCH NSD2 LMTK2 PCDHA3 MDC1 SETBP1 PALM PCNX1 ZNF646 | 1.00e-07 | 529 | 229 | 17 | 14621295 | |
| Pubmed | ZHX3 SETD1B USP31 MAGI2 STARD9 NAV1 RIPOR1 MICAL3 TCF20 PSD3 KANSL1 TENM3 SRRM2 SPEN SENP7 | 1.01e-07 | 407 | 229 | 15 | 12693553 | |
| Pubmed | ARHGAP32 SIPA1L3 MPDZ NFASC FYCO1 BCL9 NEK9 SYNGAP1 SIRPG CEP170 MAGI2 DST NAV1 UNC79 TBL1X TCF20 ANK2 NTRK2 GRIN2A SPTBN4 AGRN LRRFIP1 MTSS2 | 1.22e-07 | 963 | 229 | 23 | 28671696 | |
| Pubmed | ARHGAP32 MAP1B PSMD7 SYNGAP1 CEP170 MAGI2 NAV1 RELCH ASRGL1 ANK2 GOPC NTRK2 ATG2B PSD3 LMTK2 RICTOR TACC2 GRIN2A RAB3GAP1 TRAP1 MAP1S KNDC1 PALM CRYBG3 LRRFIP1 | 1.65e-07 | 1139 | 229 | 25 | 36417873 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.69e-07 | 20 | 229 | 5 | 29785026 | |
| Pubmed | ARHGAP32 HIVEP1 ABL2 ARID4B NCKAP5 ITGB4 KMT2C DST ARHGAP31 NAV1 DOCK1 TCF20 RBBP6 CFAP36 KANSL1 AKAP13 | 1.74e-07 | 486 | 229 | 16 | 20936779 | |
| Pubmed | NR2C2 ATP7A ECD MPDZ PSMD7 TNFRSF10B MDH2 USP31 R3HCC1L CASKIN2 FAM135A NENF NUDT19 TOR1AIP2 ANK2 GOPC HSPA4L PSD3 NOL11 RICTOR RAB11FIP1 RAB3GAP1 PALM KIRREL1 AKAP13 CRYBG3 SRRM2 QRSL1 HERC5 | 1.92e-07 | 1487 | 229 | 29 | 33957083 | |
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 2.82e-07 | 3 | 229 | 3 | 29477871 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 NR2C2 HIVEP1 ARID4B CWC27 CASZ1 BAP1 SGO2 BRWD1 TCF20 RBBP5 NSD2 IWS1 RLF MDC1 SPEN SENP7 | 6.98e-07 | 608 | 229 | 17 | 36089195 |
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 8.50e-07 | 27 | 229 | 5 | 33417976 | |
| Pubmed | ZHX3 NR2C2 ARHGAP32 HIVEP1 ARID4B ZMYND8 PSMD7 BCL9 PHF21A BAP1 KMT2C DST ALMS1 TBL1X IKZF3 TCF20 HSPA4L RBBP5 RBBP6 RLF CHCHD4 KANSL1 MDC1 MARF1 CEP152 SRRM2 SPEN | 9.65e-07 | 1429 | 229 | 27 | 35140242 | |
| Pubmed | Neurotrophin receptors: a window into neuronal differentiation. | 1.12e-06 | 4 | 229 | 3 | 1327010 | |
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 18319596 | ||
| Pubmed | Differential expression of neurotrophin receptors during renal development. | 1.12e-06 | 4 | 229 | 3 | 8306895 | |
| Pubmed | Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. | 1.12e-06 | 4 | 229 | 3 | 17971243 | |
| Pubmed | Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. | 1.12e-06 | 4 | 229 | 3 | 9927421 | |
| Pubmed | ZHX3 ARHGAP32 HIVEP1 ARID4B BCL9 CASZ1 MEPE TTBK2 TOR1AIP2 TCF20 RASA2 IDE RAB3GAP1 TRAPPC12 AASS ASXL3 SPEN | 1.34e-06 | 638 | 229 | 17 | 31182584 | |
| Pubmed | RAPGEF6 SIPA1L3 ECD MPDZ DST ALMS1 MICAL3 ATG2B CEP152 CRYBG3 | 1.42e-06 | 209 | 229 | 10 | 36779422 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ARHGAP32 ATP7A TNFRSF10B DST PTPRF CASKIN2 ARHGAP31 GOPC MPZL1 PSD3 RICTOR FRMD6 KIRREL1 | 1.53e-06 | 377 | 229 | 13 | 38117590 |
| Pubmed | ARID4B ZMYND8 TNFRSF10B PHF21A GJD4 CEP170 ALMS1 BRWD1 TOR1AIP2 NID2 GOPC RBBP6 NSD2 CFAP36 RICTOR RAB11FIP1 TEP1 SETD2 FMN2 CRYBG3 SRRM2 SENP7 ZNF646 | 1.55e-06 | 1116 | 229 | 23 | 31753913 | |
| Pubmed | RAPGEF6 SIPA1L3 MPDZ CEP170 DST ALMS1 NAV1 RICTOR RAB11FIP1 ANKRD44 MAP1S KIRREL1 CEP152 DMTN | 1.82e-06 | 446 | 229 | 14 | 24255178 | |
| Pubmed | 2.36e-06 | 15 | 229 | 4 | 12056414 | ||
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.57e-06 | 59 | 229 | 6 | 23754746 | |
| Pubmed | 2.74e-06 | 225 | 229 | 10 | 12168954 | ||
| Pubmed | Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. | 2.79e-06 | 5 | 229 | 3 | 21102451 | |
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 18428117 | ||
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 9472042 | ||
| Pubmed | Expression of neurotrophin receptors by retinoinvasive uveal melanoma. | 2.79e-06 | 5 | 229 | 3 | 22343487 | |
| Pubmed | RAPGEF6 MAP1B MPDZ NEK9 CEP170 KMT2C ALMS1 MED12 TCF20 RBBP6 ATG2B SETD2 MDC1 SPEN LRRFIP1 | 4.23e-06 | 549 | 229 | 15 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 RAPGEF6 MAP1B ECD ZMYND8 PSMD7 MDH2 NEK9 PHF21A CEP170 R3HCC1L DST ALMS1 ANK2 RBBP6 ATG2B TACC2 SETD2 TRAP1 HERC5 | 4.38e-06 | 934 | 229 | 20 | 33916271 |
| Pubmed | ARHGAP32 ATP7A ABL2 MAP1B MPDZ CEP170 DST MICAL3 FAM135A MED12 DOCK1 ANK2 HSPA4L ATG2B PSD3 RICTOR CRYBG3 | 5.37e-06 | 708 | 229 | 17 | 39231216 | |
| Pubmed | Genetic evidence for selective neurotrophin 3 signalling through TrkC but not TrkB in vivo. | 5.55e-06 | 6 | 229 | 3 | 16142215 | |
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 10357931 | ||
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 9728914 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 5.55e-06 | 6 | 229 | 3 | 23728480 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP1B SIPA1L3 TTC14 NFASC NEK9 CASZ1 CEP170 KMT2C NAV1 RIPOR1 MICAL3 TBL1X DOCK1 CACNA1C RASA2 NSD2 SLITRK3 IDE TEP1 RLF SPTBN4 ANKRD44 SETBP1 KNDC1 AKAP13 INVS | 6.42e-06 | 1489 | 229 | 26 | 28611215 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ATP7A ABL2 SIPA1L3 PSMD7 PIGG USP31 NAV1 FAM135A NENF MPZL1 RICTOR RAB11FIP1 TENM3 TMF1 PALM CEP152 AGRN | 6.57e-06 | 719 | 229 | 17 | 35337019 |
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 8.17e-06 | 20 | 229 | 4 | 35224516 | |
| Pubmed | Boundary Caps Give Rise to Neurogenic Stem Cells and Terminal Glia in the Skin. | 8.17e-06 | 20 | 229 | 4 | 26212662 | |
| Pubmed | MAP1B ZGRF1 ITGB4 DST STARD9 ATG2B CHCHD4 TRAP1 ASXL3 MDC1 SETBP1 KIRREL1 LRRC37B SRRM2 | 9.00e-06 | 513 | 229 | 14 | 25798074 | |
| Pubmed | ARHGAP32 MAP1B SIPA1L3 NFASC MDH2 SYNGAP1 CEP170 USP31 MAGI2 DST NAV1 MICAL3 ASRGL1 ANK2 HSPA4L PSD3 GRIN2A SPTBN4 MAP1S VCAN PLXNA4 KNDC1 PALM DMTN LRRFIP1 | 9.70e-06 | 1431 | 229 | 25 | 37142655 | |
| Pubmed | HIVEP1 ZMYND8 DST PTPRF NID2 FLT4 NELFCD RBBP6 SIAH1 E4F1 RLF MTMR4 KANSL1 TENM3 INVS | 1.02e-05 | 591 | 229 | 15 | 15231748 | |
| Pubmed | 1.54e-05 | 8 | 229 | 3 | 18752272 | ||
| Pubmed | 1.54e-05 | 8 | 229 | 3 | 9331334 | ||
| Pubmed | 1.54e-05 | 8 | 229 | 3 | 9640332 | ||
| Pubmed | Pacinian corpuscle development involves multiple Trk signaling pathways. | 1.54e-05 | 8 | 229 | 3 | 15376326 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NR2C2 ARID4B ZMYND8 ZNF205 CASZ1 PHF21A BAP1 KMT2C DST TBL1X TCF20 RBBP5 RBBP6 NSD2 NOL11 E4F1 WTAP IWS1 SETD2 KANSL1 MDC1 SRRM2 SPEN | 1.72e-05 | 1294 | 229 | 23 | 30804502 |
| Pubmed | PCDHA9 ABL2 MPDZ MDH2 SIRPG RIPOR1 GOPC NTRK3 PSD3 PCDHA7 PALM EXOC2 | 1.78e-05 | 405 | 229 | 12 | 38187761 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZHX3 NR2C2 HIVEP1 ARID4B MAP1B ZMYND8 ZNF207 CEP170 BRCA2 SGO2 TCF20 RBBP6 NSD2 NOL11 SETD2 MDC1 MARF1 SRRM2 SPEN | 2.09e-05 | 954 | 229 | 19 | 36373674 |
| Pubmed | 2.30e-05 | 9 | 229 | 3 | 22665483 | ||
| Pubmed | Genome-wide association study of smoking initiation and current smoking. | 2.30e-05 | 9 | 229 | 3 | 19268276 | |
| Pubmed | 2.30e-05 | 9 | 229 | 3 | 26671463 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | AHI1 CDH23 ZNF207 PSMD7 NEK9 PHF21A CEP170 NAV1 RIPOR1 CCDC93 WDR24 TOR1AIP2 RELCH GOPC UBE3B ATG2B RAB11FIP1 TRAP1 NPHP3 IGHA2 MARF1 EXOC2 INVS | 2.37e-05 | 1321 | 229 | 23 | 27173435 |
| Pubmed | 2.44e-05 | 26 | 229 | 4 | 26857994 | ||
| Pubmed | 2.60e-05 | 130 | 229 | 7 | 12421765 | ||
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 2.63e-05 | 53 | 229 | 5 | 15572359 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ZHX3 ZMYND8 PSMD7 TTC6 SYNGAP1 KMT2C MICAL3 MED12 CACNA1C HSPA4L CCDC187 MAP1S HYDIN | 2.93e-05 | 497 | 229 | 13 | 36774506 |
| Pubmed | RAPGEF6 MAP1B MPDZ LPIN1 DST CASKIN2 MICAL3 ARHGEF28 RBBP5 UBE3B RICTOR MARF1 AKAP13 CRYBG3 AGRN | 3.06e-05 | 650 | 229 | 15 | 38777146 | |
| Pubmed | MAP1B CWC27 SIPA1L3 ECD DACT2 PSMD7 MDH2 DST STARD9 CACNA1C ANK2 HSPA4L NELFCD NSD2 TAF1B SPTBN4 TRAP1 MARF1 PLXNA4 PALM CFAP74 SPEN BTNL9 CFAP46 | 3.22e-05 | 1442 | 229 | 24 | 35575683 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.23e-05 | 184 | 229 | 8 | 32908313 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ARHGAP32 ZGRF1 ZMYND8 NCKAP5 MAGI2 DST VILL ZNF648 SGO2 TAF1B SENP7 | 3.25e-05 | 363 | 229 | 11 | 14691545 |
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 18203754 | ||
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 11493560 | ||
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 20219210 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 3.31e-05 | 28 | 229 | 4 | 33523829 | |
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 | 1.58e-16 | 22 | 224 | 11 | int:PCDHA10 |
| Interaction | PCDHA7 interactions | 6.13e-11 | 14 | 224 | 7 | int:PCDHA7 | |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.45e-10 | 55 | 224 | 10 | int:PCDHA8 |
| Interaction | PCDHA11 interactions | 8.58e-10 | 19 | 224 | 7 | int:PCDHA11 | |
| Interaction | NUP43 interactions | NR2C2 HIVEP1 SETD1B ARID4B ZMYND8 TTC14 PHF21A DST BRCA2 MED12 TCF20 RBBP5 RBBP6 NSD2 MUC19 NOL11 KTI12 RICTOR IWS1 RLF SETD2 KANSL1 TRAPPC12 MDC1 MARF1 SRRM2 SPEN | 1.80e-09 | 625 | 224 | 27 | int:NUP43 |
| Interaction | PCDHA1 interactions | 1.97e-08 | 9 | 224 | 5 | int:PCDHA1 | |
| Interaction | PHF21A interactions | RAPGEF6 HIVEP1 IP6K3 ZGRF1 ZMYND8 NEK9 PHF21A BAP1 DST ALMS1 BRCA2 NAV1 CCDC93 NELFCD ATG2B RLF TMF1 CRYBG3 | 6.00e-08 | 343 | 224 | 18 | int:PHF21A |
| Interaction | SFN interactions | ARHGAP32 RAPGEF6 ABL2 MAP1B SIPA1L3 BAP1 CEP170 USP31 DST ALMS1 NAV1 ARHGEF28 NTRK3 LMTK2 RICTOR RAB11FIP1 MTMR4 FRMD6 AASS FMN2 AKAP13 CRYBG3 SRRM2 DMTN INVS MTSS2 | 6.20e-08 | 692 | 224 | 26 | int:SFN |
| Interaction | YWHAH interactions | ARHGAP32 RAPGEF6 HIVEP1 ABL2 SIPA1L3 MPDZ PSMD7 BAP1 SYNGAP1 CEP170 USP31 DST ALMS1 CASKIN2 STARD9 NAV1 ARHGEF28 TCF20 NELFCD PSD3 LMTK2 RICTOR RAB11FIP1 MTMR4 SNCAIP FRMD6 AASS FMN2 AKAP13 CEP152 CRYBG3 SRRM2 DMTN MTSS2 | 6.33e-08 | 1102 | 224 | 34 | int:YWHAH |
| Interaction | PCDHA3 interactions | 7.95e-08 | 34 | 224 | 7 | int:PCDHA3 | |
| Interaction | OCLN interactions | ARHGAP32 RAPGEF6 ATP7A SIPA1L3 USP31 DST CASKIN2 MICAL3 FAM135A ANK2 GOPC NTRK2 PSD3 LMTK2 RICTOR RAB11FIP1 TGOLN2 FMN2 PALM KIRREL1 PCNX1 | 2.04e-07 | 500 | 224 | 21 | int:OCLN |
| Interaction | PCDHA4 interactions | 3.20e-07 | 60 | 224 | 8 | int:PCDHA4 | |
| Interaction | C11orf52 interactions | ARHGAP32 ATP7A SIPA1L3 MPDZ USP31 DST PTPRF CASKIN2 MICAL3 FAM135A MPZL1 PSD3 RICTOR FMN2 PALM KIRREL1 | 4.35e-07 | 311 | 224 | 16 | int:C11orf52 |
| Interaction | MLYCD interactions | 8.38e-07 | 30 | 224 | 6 | int:MLYCD | |
| Interaction | PCDHA9 interactions | 1.26e-06 | 32 | 224 | 6 | int:PCDHA9 | |
| Interaction | YWHAZ interactions | NR2C2 ARHGAP32 RAPGEF6 HIVEP1 ABL2 CWC27 SIPA1L3 MDH2 BAP1 SYNGAP1 CEP170 USP31 DST STARD9 NAV1 ARHGEF28 NELFCD PSD3 NOL11 RICTOR TACC2 RAB11FIP1 WTAP MTMR4 FRMD6 IGHA2 AASS ASXL3 MDC1 AKAP13 EXOC2 DMTN SENP7 INVS MTSS2 | 1.41e-06 | 1319 | 224 | 35 | int:YWHAZ |
| Interaction | PCDHGA10 interactions | 1.66e-06 | 19 | 224 | 5 | int:PCDHGA10 | |
| Interaction | EPHA2 interactions | ARHGAP32 RAPGEF6 ATP7A ABL2 USP31 DST MICAL3 FAM135A NUDT19 TOR1AIP2 FLT4 GOPC NTRK2 NTRK3 TPTE2 MPZL1 PSD3 RICTOR RAB11FIP1 TGOLN2 TENM3 PALM KIRREL1 MTSS2 | 1.70e-06 | 719 | 224 | 24 | int:EPHA2 |
| Interaction | PCDHA6 interactions | 1.79e-06 | 9 | 224 | 4 | int:PCDHA6 | |
| Interaction | HDAC1 interactions | ZHX3 NR2C2 RAPGEF6 HIVEP1 ARID4B ZGRF1 ZMYND8 NEK9 CASZ1 PHF21A BAP1 DST ALMS1 BRCA2 NAV1 MED12 TBL1X IKZF3 TCF20 RBBP5 NSD2 TAF1B ATG2B E4F1 RLF SNAI2 TMF1 CRYBG3 SPEN HERC5 LRRFIP1 | 2.07e-06 | 1108 | 224 | 31 | int:HDAC1 |
| Interaction | KDM1A interactions | NR2C2 RAPGEF6 HIVEP1 ZGRF1 ZMYND8 FYCO1 NEK9 PHF21A BAP1 DST ALMS1 BRCA2 NAV1 MED12 CCDC93 TBL1X IKZF3 TCF20 NELFCD RBBP5 NSD2 ATG2B RLF KANSL1 SNAI2 TMF1 CEP152 CRYBG3 | 2.11e-06 | 941 | 224 | 28 | int:KDM1A |
| Interaction | RCOR1 interactions | RAPGEF6 HIVEP1 ZGRF1 ZMYND8 NEK9 PHF21A BAP1 DST ALMS1 BRCA2 MED12 CCDC93 TBL1X NELFCD ATG2B RLF TMF1 SPEN LRRFIP1 | 2.91e-06 | 494 | 224 | 19 | int:RCOR1 |
| Interaction | FLT3 interactions | PCDHA9 BRCA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 SIAH1 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TRAP1 | 2.95e-06 | 318 | 224 | 15 | int:FLT3 |
| Interaction | FOXK2 interactions | SETD1B ARID4B MAP1B FAXC GJD4 BAP1 TBL1X RBBP5 MTMR4 KANSL1 ASXL3 TMF1 | 8.65e-06 | 225 | 224 | 12 | int:FOXK2 |
| Interaction | PCDHA12 interactions | 1.14e-05 | 46 | 224 | 6 | int:PCDHA12 | |
| Interaction | MED4 interactions | AHI1 IP6K3 MAP1B ECD PSMD7 NEK9 CEP170 DST ALMS1 NAV1 MICAL3 MED12 TPTE2 ATG2B FRMD6 CEP152 LRRFIP1 | 1.24e-05 | 450 | 224 | 17 | int:MED4 |
| Interaction | PCDHA2 interactions | 1.36e-05 | 14 | 224 | 4 | int:PCDHA2 | |
| Interaction | CCDC71 interactions | 1.52e-05 | 72 | 224 | 7 | int:CCDC71 | |
| Interaction | LYN interactions | NR2C2 ARHGAP32 ATP7A CDH23 USP31 DST CASKIN2 MICAL3 FAM135A ARHGEF28 ANK2 NSD2 TPTE2 MPZL1 PSD3 LMTK2 RICTOR RAB11FIP1 FMN2 PALM KIRREL1 SRRM2 | 1.87e-05 | 720 | 224 | 22 | int:LYN |
| Interaction | NCK1 interactions | ARHGAP32 ABL2 NFASC NCKAP5 CEP170 MAGI2 CASKIN2 FLT4 GOPC NSD2 NTRK2 NTRK3 | 1.95e-05 | 244 | 224 | 12 | int:NCK1 |
| Interaction | LAMTOR1 interactions | ATP7A FYCO1 TNFRSF10B BAP1 DST PTPRF CASKIN2 FAM135A NUDT19 RELCH GOPC NELFCD MPZL1 PSD3 LMTK2 RICTOR RAB11FIP1 TGOLN2 FMN2 PALM KIRREL1 CRYBG3 | 1.96e-05 | 722 | 224 | 22 | int:LAMTOR1 |
| Interaction | YWHAG interactions | ARHGAP32 RAPGEF6 HIVEP1 ABL2 SIPA1L3 MPDZ BAP1 SYNGAP1 CEP170 USP31 LPIN1 DST ALMS1 CASKIN2 STARD9 NAV1 ARHGEF28 NELFCD PSD3 LMTK2 RICTOR RAB11FIP1 TGOLN2 MTMR4 FRMD6 AASS FMN2 AKAP13 SRRM2 DMTN MTSS2 | 2.23e-05 | 1248 | 224 | 31 | int:YWHAG |
| Interaction | GOLGA1 interactions | RAPGEF6 R3HCC1L DST ALMS1 NAV1 ATG2B RAB3GAP1 TMF1 CEP152 CRYBG3 | 3.99e-05 | 183 | 224 | 10 | int:GOLGA1 |
| Interaction | KTI12 interactions | 4.01e-05 | 35 | 224 | 5 | int:KTI12 | |
| Interaction | PCDHA13 interactions | 4.59e-05 | 7 | 224 | 3 | int:PCDHA13 | |
| Interaction | TBXT interactions | 4.66e-05 | 116 | 224 | 8 | int:TBXT | |
| Interaction | MAPRE3 interactions | SIPA1L3 NCKAP5 CEP170 TTBK2 DST NAV1 CHRDL2 SIAH1 TACC2 MAP1S MARF1 | 5.58e-05 | 230 | 224 | 11 | int:MAPRE3 |
| Interaction | PFN1 interactions | NR2C2 RAPGEF6 MDH2 BAP1 R3HCC1L ALMS1 NAV1 MICAL3 FAM135A DOCK1 ANK2 TMF1 FMN2 AKAP13 CEP152 CRYBG3 MTSS2 | 5.87e-05 | 509 | 224 | 17 | int:PFN1 |
| Interaction | CAV1 interactions | ARHGAP32 RAPGEF6 TNFRSF10B USP31 DST PTPRF CASKIN2 NGFR MICAL3 FAM135A GOPC MPZL1 PSD3 LMTK2 RICTOR RAB11FIP1 TGOLN2 TMF1 FMN2 PALM KIRREL1 | 6.19e-05 | 724 | 224 | 21 | int:CAV1 |
| Interaction | LONP2 interactions | 6.45e-05 | 62 | 224 | 6 | int:LONP2 | |
| Interaction | CXADR interactions | ARHGAP32 SIPA1L3 DST CASKIN2 FAM135A GOPC NTRK2 MPZL1 PSD3 RICTOR RAB11FIP1 TGOLN2 PALM KIRREL1 | 7.04e-05 | 369 | 224 | 14 | int:CXADR |
| Interaction | CTDSPL interactions | 7.51e-05 | 92 | 224 | 7 | int:CTDSPL | |
| Interaction | ZYX interactions | ARHGAP32 SIPA1L3 TTC6 PHF21A ALMS1 ARHGAP31 FAM135A ANK2 PSD3 SIAH1 AKAP13 CEP152 CRYBG3 | 8.52e-05 | 329 | 224 | 13 | int:ZYX |
| Interaction | ARHGEF10 interactions | 9.20e-05 | 95 | 224 | 7 | int:ARHGEF10 | |
| Interaction | DDX41 interactions | 1.03e-04 | 166 | 224 | 9 | int:DDX41 | |
| Interaction | FRMD5 interactions | 1.09e-04 | 68 | 224 | 6 | int:FRMD5 | |
| Interaction | RHOQ interactions | ARHGAP32 ABL2 TNFRSF10B DST PTPRF CASKIN2 MICAL3 FAM135A RELCH GOPC PSD3 RICTOR RAB11FIP1 PALM KIRREL1 | 1.35e-04 | 442 | 224 | 15 | int:RHOQ |
| Interaction | PPA2 interactions | 1.75e-04 | 140 | 224 | 8 | int:PPA2 | |
| Interaction | GUSBP5 interactions | 1.87e-04 | 75 | 224 | 6 | int:GUSBP5 | |
| Interaction | CALD1 interactions | ARID4B SIPA1L3 BAP1 DST MICAL3 TPTE2 RICTOR WTAP TGOLN2 TRAP1 INVS | 1.95e-04 | 265 | 224 | 11 | int:CALD1 |
| Interaction | TOP3B interactions | RAPGEF6 SETD1B SIPA1L3 FYCO1 PIGG BCL9 ITGB4 CASZ1 BAP1 KMT2C DST PTPRF NAV1 RIPOR1 MICAL3 MED12 WDR24 NUDT19 NSD2 UBE3B LMTK2 KTI12 TEP1 KANSL1 MAP1S TRAPPC12 MDC1 PALM PCNX1 AKAP13 SPEN AGRN | 1.97e-04 | 1470 | 224 | 32 | int:TOP3B |
| Interaction | RAC3 interactions | ARHGAP32 ATP7A ABL2 TNFRSF10B PTPRF CASKIN2 MICAL3 FAM135A RELCH MPZL1 PSD3 RICTOR SLITRK3 RAB11FIP1 TENM3 FMN2 PALM KIRREL1 | 2.03e-04 | 619 | 224 | 18 | int:RAC3 |
| Interaction | ARRDC3 interactions | MAP1B CWC27 TNFRSF10B ITGB4 MAGI2 LPIN1 PTPRF NUDT19 RBBP6 SPEN | 2.13e-04 | 224 | 224 | 10 | int:ARRDC3 |
| Interaction | PAX6 interactions | NR2C2 HIVEP1 ARID4B FYCO1 BCL9 PHF21A BAP1 KMT2C TBL1X IKZF3 RBBP5 RLF TRAP1 | 2.43e-04 | 366 | 224 | 13 | int:PAX6 |
| Interaction | ATN1 interactions | 2.53e-04 | 187 | 224 | 9 | int:ATN1 | |
| Interaction | TBR1 interactions | 2.72e-04 | 113 | 224 | 7 | int:TBR1 | |
| Interaction | BUB3 interactions | NR2C2 SETD1B MAP1B STK17A ZNF207 KMT2C IKZF3 RBBP5 KANSL1 ASXL3 | 2.82e-04 | 232 | 224 | 10 | int:BUB3 |
| Interaction | SNRNP40 interactions | NR2C2 HIVEP1 ECD TTC14 ZNF207 BCL9 PHF21A BRCA2 MED12 TBL1X TCF20 RBBP6 NSD2 NOL11 SETD2 MDC1 SRRM2 SPEN | 2.88e-04 | 637 | 224 | 18 | int:SNRNP40 |
| Interaction | FLOT1 interactions | ARHGAP32 MPDZ DST CASKIN2 FAM135A ANK2 PSD3 LMTK2 RICTOR RAB11FIP1 SCARB2 FMN2 PALM KIRREL1 CRYBG3 | 2.93e-04 | 475 | 224 | 15 | int:FLOT1 |
| Interaction | AR interactions | ZHX3 NR2C2 HIVEP1 ABL2 ZMYND8 PSMD7 BCL9 NEK9 CASZ1 PHF21A BAP1 KMT2C MED12 TBL1X TCF20 NELFCD RBBP5 NSD2 IDE RAB11FIP1 USP26 NLRP10 MDC1 TMF1 | 2.96e-04 | 992 | 224 | 24 | int:AR |
| Interaction | KCNA3 interactions | ARHGAP32 ATP7A ABL2 MAP1B MPDZ FYCO1 CEP170 KMT2C DST MICAL3 FAM135A MED12 DOCK1 ANK2 HSPA4L RBBP6 NTRK2 ATG2B PSD3 RICTOR CRYBG3 SPEN | 2.98e-04 | 871 | 224 | 22 | int:KCNA3 |
| Interaction | NTRK3 interactions | ARHGAP32 RAPGEF6 SYNGAP1 NGFR FAM135A NUDT19 GOPC HSPA4L NTRK2 NTRK3 RICTOR RAB11FIP1 PLXNA4 | 3.00e-04 | 374 | 224 | 13 | int:NTRK3 |
| Interaction | LAMP1 interactions | ATP7A TNFRSF10B DST FAM135A WDR24 RELCH GOPC NTRK3 MPZL1 PSD3 RICTOR RAB11FIP1 TGOLN2 TENM3 TRAPPC12 SCARB2 FMN2 KIRREL1 | 3.28e-04 | 644 | 224 | 18 | int:LAMP1 |
| Interaction | YWHAE interactions | ARHGAP32 AHI1 RAPGEF6 HIVEP1 ABL2 MAP1B SIPA1L3 BAP1 SYNGAP1 CEP170 USP31 LPIN1 DST NAV1 ARHGEF28 PSD3 RICTOR TACC2 RAB11FIP1 WTAP TGOLN2 MTMR4 FRMD6 AASS AKAP13 SRRM2 AGRN DMTN | 3.50e-04 | 1256 | 224 | 28 | int:YWHAE |
| Interaction | H3C14 interactions | 3.64e-04 | 156 | 224 | 8 | int:H3C14 | |
| Cytoband | 5q31 | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.97e-13 | 115 | 229 | 12 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | RAPGEF6 PCDHA9 DELE1 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.16e-10 | 298 | 229 | 14 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.21e-13 | 64 | 147 | 12 | 20 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.79e-06 | 161 | 147 | 9 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.74e-05 | 40 | 147 | 5 | 321 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.61e-04 | 34 | 147 | 4 | 487 | |
| GeneFamily | Fibronectin type III domain containing | 3.37e-04 | 160 | 147 | 7 | 555 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZHX3 HIVEP1 ZFP3 ZNF366 ZNF205 ZNF207 CASZ1 ZNF648 ZNF438 IKZF3 E4F1 RLF SNAI2 ZNF646 | 2.18e-03 | 718 | 147 | 14 | 28 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.49e-03 | 115 | 147 | 5 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.83e-03 | 10 | 147 | 2 | 830 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 MAP1B ZMYND8 TTC14 FAXC NFASC CASZ1 MAGI2 LPIN1 NAV1 MICAL3 ANKRD18A SARDH UNC79 BRWD1 CACNA1C IKZF3 ANK2 NTRK3 MUC19 PCDHA7 RICTOR ANKRD44 LRRN3 ASXL3 VCAN PLXNA4 HYDIN DMTN | 1.16e-07 | 1106 | 227 | 29 | M39071 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 ATP7A TTC14 SIRPG MAGI2 KMT2C DST ARHGAP31 RIPOR1 ADGRF5 FAM135A TOR1AIP2 NID2 GOPC RASA2 RBBP6 PSD3 RICTOR SNCAIP FRMD6 KIRREL1 BTNL9 LRRFIP1 | 3.18e-06 | 888 | 227 | 23 | MM1018 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.24e-06 | 261 | 227 | 12 | MM1277 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 ATP7A TTC14 MAGI2 KMT2C DST ARHGAP31 RIPOR1 ADGRF5 FAM135A TOR1AIP2 NID2 GOPC RASA2 RBBP6 PSD3 RICTOR SNCAIP FRMD6 KIRREL1 BTNL9 LRRFIP1 | 5.74e-06 | 854 | 227 | 22 | M1533 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.95e-06 | 238 | 227 | 11 | M2020 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ACAA1 MAP1B ZMYND8 FAXC NFASC FYCO1 PIGG DST ALMS1 NAV1 MICAL3 RBBP6 NSD2 MPZL1 RICTOR ANKRD44 LRRN3 MTMR4 KANSL1 GOLPH3L SCARB2 MARF1 FMN2 PCNX1 INVS | 1.17e-05 | 1102 | 227 | 25 | M2369 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | ZGRF1 FYCO1 CMYA5 CRLF2 KIAA1210 DST BRCA2 RIPOR1 CCDC93 RASA2 NTRK2 TAF1B UBE3B ATG2B AMDHD1 RAB11FIP1 LRRN3 TRAPPC12 KNDC1 AGRN DMTN SENP7 | 1.28e-05 | 899 | 227 | 22 | M2242 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ACAA1 MAP1B ZMYND8 FAXC NFASC FYCO1 PIGG DST ALMS1 NAV1 MICAL3 RBBP6 NSD2 MPZL1 RICTOR ANKRD44 LRRN3 MTMR4 KANSL1 GOLPH3L SCARB2 MARF1 FMN2 PCNX1 INVS | 1.63e-05 | 1124 | 227 | 25 | MM1070 |
| Coexpression | CHEN_LIVER_METABOLISM_QTL_CIS | 1.93e-05 | 95 | 227 | 7 | M1947 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | ZGRF1 FYCO1 CMYA5 CRLF2 DST BRCA2 RIPOR1 ANKRD18A CCDC93 RASA2 NTRK2 TAF1B UBE3B ATG2B AMDHD1 RAB11FIP1 LRRN3 TRAPPC12 KNDC1 AGRN DMTN SENP7 | 2.14e-05 | 930 | 227 | 22 | MM893 |
| Coexpression | CHEN_LIVER_METABOLISM_QTL_CIS | 2.52e-05 | 99 | 227 | 7 | MM827 | |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 2.71e-05 | 41 | 227 | 5 | M2000 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZHX3 MAP1B SUSD6 NFASC RCBTB2 BCL9 LPIN1 KMT2C DST UNC79 FAM135A HSPA4L CFAP36 PSD3 RAB11FIP1 TGOLN2 RAB3GAP1 PDE8B SETBP1 FMN2 EXOC2 MTSS2 | 2.77e-05 | 946 | 227 | 22 | M39169 |
| Coexpression | MIKKELSEN_ES_HCP_WITH_H3K27ME3 | 3.05e-05 | 42 | 227 | 5 | MM1275 | |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 3.26e-05 | 103 | 227 | 7 | M1967 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NR2C2 AHI1 HIVEP1 ABL2 ARID4B TTBK2 R3HCC1L DST RIPOR1 CCDC93 BRWD1 TCF20 HSPA4L RAB11FIP1 RLF SETD2 MAP1S GOLPH3L TMF1 PCNX1 | 3.48e-05 | 822 | 227 | 20 | M6782 |
| Coexpression | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 | 3.92e-05 | 106 | 227 | 7 | MM1265 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 HIVEP1 MAP1B ZMYND8 PHF21A CEP170 DST BRCA2 MICAL3 CCDC93 TBL1X DOCK1 PSD3 RLF SETD2 RAB3GAP1 AKAP13 CRYBG3 SPEN LRRFIP1 | 6.10e-05 | 856 | 227 | 20 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 HIVEP1 MAP1B ZMYND8 PHF21A CEP170 DST MICAL3 CCDC93 TBL1X SETD2 RAB3GAP1 MARF1 SPEN | 6.12e-05 | 466 | 227 | 14 | M13522 |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 6.33e-05 | 199 | 227 | 9 | M6443 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 6.33e-05 | 199 | 227 | 9 | M5893 | |
| Coexpression | GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 6.58e-05 | 200 | 227 | 9 | M5859 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | SETD1B WBP1L NLRC4 TCF20 RICTOR CHCHD4 KANSL1 TRAPPC12 MARF1 | 6.58e-05 | 200 | 227 | 9 | M5870 |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP | 6.58e-05 | 200 | 227 | 9 | M6019 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | AHI1 CDHR2 FAXC NFASC MEPE KMT2C NAV1 ADGRF5 ZNF438 FLT4 ANK2 PSD3 PCDHA13 PCDHA11 MTMR4 RGS18 PLXNA4 KIRREL1 MUCL3 HERC5 | 7.98e-05 | 873 | 227 | 20 | M16009 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.03e-04 | 212 | 227 | 9 | M39221 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP | 1.13e-04 | 168 | 227 | 8 | M6704 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.18e-04 | 169 | 227 | 8 | M39230 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.41e-04 | 221 | 227 | 9 | M39222 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | MAP1B FAXC NFASC CASZ1 UNC79 CACNA1C ANK2 PCDHA7 LRRN3 TENM3 PLXNA4 DMTN | 1.61e-04 | 389 | 227 | 12 | M39073 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.82e-04 | 180 | 227 | 8 | M8239 | |
| Coexpression | LIU_SOX4_TARGETS_UP | 2.16e-04 | 139 | 227 | 7 | M17450 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | AHI1 MAP1B TTC14 BCL9 PHF21A USP31 PTPRF TBL1X DOCK1 RELCH IDE KANSL1 ASXL3 VCAN MYOCD AGRN ZNF646 | 8.27e-07 | 385 | 225 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | ZHX3 SETD1B MAP1B BCL9 TTC6 USP31 DST DOCK1 RELCH PCDHA11 ANKRD44 SNCAIP KANSL1 VCAN FMN2 MYOCD AGRN | 1.77e-06 | 407 | 225 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | AHI1 MAP1B TTC14 ZNF207 USP31 TBL1X DOCK1 RELCH IDE RLF KANSL1 ASXL3 VCAN MYOCD AGRN | 2.61e-06 | 330 | 225 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 4.42e-06 | 149 | 225 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | ZHX3 MAP1B ZNF207 TNFRSF10B USP31 FAM135A TBL1X DOCK1 RELCH IDE RLF KANSL1 VCAN MYOCD AGRN | 1.01e-05 | 369 | 225 | 15 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ZHX3 AHI1 SETD1B MAP1B SIPA1L3 BCL9 TTC6 USP31 DST FAM135A DOCK1 RELCH PCDHA11 ANKRD44 SNCAIP KANSL1 VCAN FMN2 AKAP13 MYOCD EXOC2 AGRN ZNF646 | 1.68e-05 | 806 | 225 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | ZHX3 AHI1 MAP1B TTC14 ZNF207 CEP170 USP31 FAM135A TBL1X DOCK1 RELCH TCF20 ANK2 RBBP6 NTRK2 PCDHA11 IDE RLF KANSL1 ASXL3 VCAN MYOCD AGRN | 2.12e-05 | 818 | 225 | 23 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | AHI1 MAP1B SIPA1L3 TTC14 BCL9 TTC6 PHF21A USP31 PTPRF TBL1X DOCK1 RELCH ANK2 NTRK2 PCDHA11 IDE KANSL1 ASXL3 VCAN FMN2 MYOCD AGRN ZNF646 | 2.12e-05 | 818 | 225 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ZHX3 AHI1 MAP1B BCL9 USP31 FAM135A DOCK1 RELCH KANSL1 VCAN MYOCD AGRN ZNF646 | 3.07e-05 | 312 | 225 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SETD1B ARID4B TTC14 NCKAP5 FREM1 MAGI2 TTBK2 DST STARD9 SGO2 FAM135A ANK2 PSD3 PCDHA11 IWS1 ANKRD44 FRMD6 ASXL3 VCAN SNAI2 FMN2 EXOC2 DMTN | 3.84e-05 | 850 | 225 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | ZHX3 MAP1B TNFRSF10B USP31 TBL1X RELCH KANSL1 VCAN MYOCD AGRN | 4.40e-05 | 194 | 225 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 4.51e-05 | 89 | 225 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 4.52e-05 | 61 | 225 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | ZHX3 SETD1B MAP1B ZNF207 TNFRSF10B USP31 DST FAM135A TBL1X DOCK1 RELCH RBBP6 PCDHA11 IDE RLF ANKRD44 KANSL1 VCAN FMN2 MYOCD EXOC2 AGRN | 5.02e-05 | 806 | 225 | 22 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | SETD1B ARID4B TTC14 NCKAP5 MAGI2 TTBK2 STARD9 SGO2 FAM135A PSD3 PCDHA11 IWS1 ANKRD44 VCAN SNAI2 DMTN | 5.45e-05 | 478 | 225 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_100 | 6.32e-05 | 8 | 225 | 3 | gudmap_developingKidney_e15.5_Medullary collecting duct_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | AHI1 RAPGEF6 DOCK1 RELCH ARHGEF28 GOPC IDE KANSL1 VCAN AGRN LRRFIP1 | 1.13e-04 | 261 | 225 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ARID4B TTC14 FYCO1 BCL9 NEK9 FREM1 PHF21A BRCA2 STARD9 SGO2 SARDH CACNA1C SPTBN4 ANKRD44 SNCAIP ASXL3 MDC1 SNAI2 AKAP13 QRSL1 | 1.37e-04 | 744 | 225 | 20 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_200 | 2.02e-04 | 51 | 225 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.13e-04 | 151 | 225 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 2.40e-04 | 116 | 225 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 2.42e-04 | 53 | 225 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | ABL2 VSIG2 MAP1B ZNF366 NCKAP5 TNFRSF10B ARHGAP31 NAV1 RIPOR1 ADGRF5 DOCK1 NID2 FLT4 ARHGEF28 ANK2 MPZL1 KTI12 GRIN2A PALM CRYBG3 LRRFIP1 | 2.80e-04 | 847 | 225 | 21 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | ZHX3 BCL9 USP31 MAGI2 DST RELCH PCDHA11 KANSL1 FRMD6 ASXL3 VCAN FMN2 AGRN | 2.85e-04 | 390 | 225 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.05e-04 | 201 | 225 | 9 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#2_top-relative-expression-ranked_200 | 3.50e-04 | 32 | 225 | 4 | gudmap_developingKidney_e15.5_Medullary collecting duct_200_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | AHI1 MAP1B NCKAP5 ALMS1 SARDH HSPA4L NTRK2 IWS1 CCNE2 SETBP1 FMN2 | 3.56e-04 | 298 | 225 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ARID4B TTC14 BCL9 BRCA2 SGO2 SARDH SPTBN4 ASXL3 MDC1 KNDC1 QRSL1 | 3.56e-04 | 298 | 225 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ARID4B MPDZ ZNF205 BCL9 BRCA2 NAV1 SARDH FAM135A BRWD1 NUDT19 WTAP IWS1 SPTBN4 MTMR4 SNCAIP KANSL1 FRMD6 CCNE2 PDE8B KNDC1 CFAP74 SENP7 MTSS2 | 3.56e-04 | 989 | 225 | 23 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.06e-04 | 209 | 225 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.17e-04 | 91 | 225 | 6 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | ZHX3 MAP1B TNFRSF10B USP31 DST TBL1X RELCH PCDHA11 ANKRD44 KANSL1 VCAN MYOCD AGRN | 4.38e-04 | 408 | 225 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 4.44e-04 | 34 | 225 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | FREM1 TTBK2 SGO2 FAM135A DOCK1 CACNA1C GOPC RBBP6 ASXL3 SNAI2 KIRREL1 | 4.58e-04 | 307 | 225 | 11 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.31e-04 | 173 | 225 | 8 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | ZHX3 AHI1 RAPGEF6 MAP1B ZNF207 DST SGO2 FAM135A DOCK1 RELCH GOPC NTRK2 WTAP KANSL1 VCAN FMN2 MYOCD BTNL9 AGRN | 5.99e-04 | 772 | 225 | 19 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | ZHX3 ARHGAP32 AHI1 PIGG FREM1 USP31 MAGI2 RIPOR1 ADGRF5 FAM135A NID2 NTRK2 MTMR4 SNCAIP ASXL3 VCAN KIRREL1 MYOCD ENPEP SENP7 | 6.14e-04 | 836 | 225 | 20 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 6.40e-04 | 178 | 225 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.40e-04 | 178 | 225 | 8 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | SIPA1L3 TTC14 MPDZ RCBTB2 TNFRSF10B NEK9 SYNGAP1 LPIN1 NGFR NAV1 TBL1X NID2 PCDHA13 PCDHA10 PCDHA6 PCDHA4 PCDHA1 TACC2 RAB11FIP1 ECHDC3 FRMD6 KIRREL1 | 6.43e-04 | 967 | 225 | 22 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ATP7A ZGRF1 BCL9 FREM1 NAV1 SGO2 PSD3 GRIN2A LRRN3 SNCAIP TENM3 ASXL3 VCAN MDC1 SNAI2 PLXNA4 MYOCD ENPEP MTSS2 | 6.47e-04 | 777 | 225 | 19 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.26e-04 | 101 | 225 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | SIPA1L3 ZMYND8 CASZ1 FREM1 UNC79 TBL1X DOCK1 TCF20 GRIN2A VCAN KIRREL1 HYDIN | 2.93e-10 | 188 | 229 | 12 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | FBXO40 NCKAP5 CMYA5 CASZ1 DST MICAL3 CACNA1C ANK2 PSD3 TACC2 AKAP13 MYOCD | 3.31e-10 | 190 | 229 | 12 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | FBXO40 NCKAP5 CMYA5 CASZ1 DST MICAL3 CACNA1C ANK2 PSD3 TACC2 AKAP13 MYOCD | 4.46e-10 | 195 | 229 | 12 | 75fc81bddb246dca3b437fb60827b1d4fe416405 |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | FBXO40 NCKAP5 CMYA5 CASZ1 MICAL3 CACNA1C ANK2 PSD3 TACC2 PDE8B MYOCD | 5.68e-09 | 194 | 229 | 11 | c3535f7cc0076653c72db582047cff053c322397 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAP1B FAXC NFASC CMYA5 ITGB4 USP31 LPIN1 NGFR HSPA4L NTRK2 NTRK3 | 6.32e-09 | 196 | 229 | 11 | a58bdf9de05d13d84211e09a933679d485bf8ab4 |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | FREM1 IKZF3 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA3 PCDHA1 VCAN SNAI2 | 1.05e-08 | 159 | 229 | 10 | b4bc888e978b1b577721b891b0af6ba9a1607044 |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | CDH23 ITGB4 BAP1 SYNGAP1 NAV1 FRMD6 GOLPH3L PCNX1 CRYBG3 ZNF646 | 1.19e-08 | 161 | 229 | 10 | fd4a79385ea967b9900dc76a3add813b894a3a28 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | MAP1B NFASC MAGI2 DST CACNA1C NTRK3 VCAN SETBP1 PLXNA4 MYOCD | 4.93e-08 | 187 | 229 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | UNC13D NCKAP5 CMYA5 CASZ1 CACNA1C ANK2 PSD3 TACC2 PDE8B MYOCD | 5.18e-08 | 188 | 229 | 10 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | FBXO40 NCKAP5 CMYA5 CASZ1 MICAL3 CACNA1C ANK2 PSD3 TACC2 MYOCD | 6.02e-08 | 191 | 229 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ARHGAP32 AHI1 MAP1B UNC79 CACNA1C NTRK2 GRIN2A SPTBN4 SETBP1 FMN2 | 8.43e-08 | 198 | 229 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-07 | 168 | 229 | 9 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-07 | 179 | 229 | 9 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-07 | 179 | 229 | 9 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.95e-07 | 184 | 229 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 187 | 229 | 9 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.92e-07 | 188 | 229 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-07 | 188 | 229 | 9 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.19e-07 | 189 | 229 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.19e-07 | 189 | 229 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.19e-07 | 189 | 229 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-07 | 190 | 229 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.47e-07 | 190 | 229 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.47e-07 | 190 | 229 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.76e-07 | 191 | 229 | 9 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.38e-07 | 193 | 229 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.13e-07 | 198 | 229 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.13e-07 | 198 | 229 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.52e-07 | 199 | 229 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-07 | 200 | 229 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-06 | 168 | 229 | 8 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-06 | 172 | 229 | 8 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-06 | 173 | 229 | 8 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.21e-06 | 179 | 229 | 8 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 4.21e-06 | 179 | 229 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 181 | 229 | 8 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 181 | 229 | 8 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 182 | 229 | 8 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-06 | 182 | 229 | 8 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 182 | 229 | 8 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.96e-06 | 183 | 229 | 8 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.16e-06 | 184 | 229 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 184 | 229 | 8 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 185 | 229 | 8 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 185 | 229 | 8 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.59e-06 | 186 | 229 | 8 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 5.59e-06 | 186 | 229 | 8 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.81e-06 | 187 | 229 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.29e-06 | 189 | 229 | 8 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.29e-06 | 189 | 229 | 8 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.29e-06 | 189 | 229 | 8 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.43e-06 | 135 | 229 | 7 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.53e-06 | 190 | 229 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.53e-06 | 190 | 229 | 8 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.53e-06 | 190 | 229 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.79e-06 | 191 | 229 | 8 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.79e-06 | 191 | 229 | 8 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 192 | 229 | 8 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 192 | 229 | 8 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-06 | 192 | 229 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.05e-06 | 192 | 229 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 193 | 229 | 8 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 193 | 229 | 8 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-06 | 193 | 229 | 8 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.61e-06 | 194 | 229 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-06 | 194 | 229 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-06 | 194 | 229 | 8 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-06 | 194 | 229 | 8 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.90e-06 | 195 | 229 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-06 | 195 | 229 | 8 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 195 | 229 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-06 | 195 | 229 | 8 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.20e-06 | 196 | 229 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 196 | 229 | 8 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 196 | 229 | 8 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 196 | 229 | 8 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 196 | 229 | 8 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-06 | 196 | 229 | 8 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 197 | 229 | 8 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 197 | 229 | 8 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 197 | 229 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 197 | 229 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.51e-06 | 197 | 229 | 8 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-06 | 198 | 229 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-06 | 198 | 229 | 8 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-06 | 198 | 229 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-06 | 198 | 229 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.16e-06 | 199 | 229 | 8 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.16e-06 | 199 | 229 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.16e-06 | 199 | 229 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.16e-06 | 199 | 229 | 8 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 9.16e-06 | 199 | 229 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.50e-06 | 200 | 229 | 8 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.50e-06 | 200 | 229 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-06 | 200 | 229 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.50e-06 | 200 | 229 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-06 | 200 | 229 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | AHI1 ZMYND8 LPIN1 PTPRF CASKIN2 MICAL3 PSD3 TEP1 MAP1S PCNX1 CEP152 DMTN | 8.00e-07 | 198 | 228 | 12 | 5242_DN |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | AHI1 SIPA1L3 ZMYND8 ALMS1 BRCA2 TBL1X PCDHA6 SETD2 SNAI2 PCNX1 CEP152 | 3.61e-06 | 190 | 228 | 11 | 3253_DN |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | MAP1B ALMS1 TBL1X RBBP5 PSD3 TEP1 TGOLN2 KIRREL1 PCNX1 AKAP13 SPEN | 3.80e-06 | 191 | 228 | 11 | 4283_DN |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | MPDZ ITGB4 NEK9 LPIN1 RIPOR1 ADGRF5 ARHGEF28 PSD3 SNAI2 AKAP13 MTSS2 | 3.80e-06 | 191 | 228 | 11 | 7417_UP |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | MAP1B ALMS1 TBL1X RBBP5 PSD3 TGOLN2 KIRREL1 PCNX1 AKAP13 CEP152 SPEN | 4.41e-06 | 194 | 228 | 11 | 4312_DN |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | ZMYND8 ZNF205 NEK9 CASZ1 ALMS1 FLT4 TAF1B SETD2 PDE8B PCNX1 AKAP13 | 4.63e-06 | 195 | 228 | 11 | 3508_DN |
| Drug | carbamyl-L-aspartate | 1.62e-05 | 16 | 228 | 4 | CID000000279 | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.30e-05 | 190 | 228 | 10 | 4306_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | TNFRSF10B TOR1AIP2 NSD2 UBE3B PSD3 TGOLN2 SETD2 KIRREL1 AKAP13 SPEN | 2.41e-05 | 191 | 228 | 10 | 4269_DN |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | MAP1B TTBK2 TBL1X TOR1AIP2 RBBP5 PSD3 TGOLN2 PCNX1 AKAP13 SPEN | 2.63e-05 | 193 | 228 | 10 | 4305_DN |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | ARHGAP32 ZMYND8 BAP1 CCDC93 BRWD1 TACC2 SETD2 RAB3GAP1 QRSL1 LRRFIP1 | 2.87e-05 | 195 | 228 | 10 | 1138_DN |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.14e-05 | 197 | 228 | 10 | 7335_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | AHI1 ZMYND8 TNFRSF10B MAGI2 BRWD1 HSPA4L ATG2B SETBP1 PALM PCNX1 | 3.27e-05 | 198 | 228 | 10 | 6907_UP |
| Drug | Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A | NR2C2 ZMYND8 DELE1 TNFRSF10B ITGB4 ALMS1 CASKIN2 CCDC93 MAP1S PCNX1 | 3.42e-05 | 199 | 228 | 10 | 7403_DN |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | SIPA1L3 ALMS1 PTPRF CASKIN2 RIPOR1 MED12 CCDC93 RLF SNAI2 QRSL1 | 3.42e-05 | 199 | 228 | 10 | 6214_DN |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 NCKAP5 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RAB3GAP1 | 1.11e-22 | 29 | 226 | 14 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.25e-12 | 87 | 226 | 12 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | AHI1 PCDHA9 ZNF366 RASA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TRAP1 | 2.24e-11 | 224 | 226 | 16 | EFO_0004833, EFO_0005090 |
| Disease | Abnormality of refraction | ZHX3 ARHGAP32 PCDHA9 CWC27 MAGI2 PTPRF TBL1X PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRIN2A RGS18 KIRREL1 AKAP13 | 1.33e-08 | 673 | 226 | 22 | HP_0000539 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 HIVEP1 SYNGAP1 NAV1 CACNA1C PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRIN2A TENM3 ASXL3 PALM | 1.75e-08 | 566 | 226 | 20 | EFO_0007660, EFO_0008354 |
| Disease | pulse pressure measurement | TDRD15 PCDHA9 MAP1B WBP1L UNC13D DELE1 ZNF831 NEK9 CASZ1 NAV1 ZNF438 ANK2 GOPC PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SPTBN4 KANSL1 AKAP13 ENPEP HYDIN | 1.06e-06 | 1392 | 226 | 29 | EFO_0005763 |
| Disease | Adenoid Cystic Carcinoma | 1.06e-06 | 100 | 226 | 8 | C0010606 | |
| Disease | neutrophil count | AHI1 PCDHA9 HIVEP1 ZNF366 CDH23 BCL9 CASZ1 ADGRF5 RASA2 MPZL1 PSD3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TGOLN2 SETD2 TRAP1 KIRREL1 AKAP13 HYDIN | 2.81e-06 | 1382 | 226 | 28 | EFO_0004833 |
| Disease | post-traumatic stress disorder symptom measurement | 3.29e-06 | 82 | 226 | 7 | EFO_0008535 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.40e-05 | 45 | 226 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | Carcinoma of lung | 2.65e-05 | 23 | 226 | 4 | C0684249 | |
| Disease | vital capacity | AHI1 PCDHA9 CWC27 UNC13D CASZ1 R3HCC1L DST RIPOR1 MICAL3 ZNF438 TCF20 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRIN2A KANSL1 | 3.01e-05 | 1236 | 226 | 24 | EFO_0004312 |
| Disease | Schizophrenia | ARHGAP32 AHI1 RAPGEF6 NFASC CMYA5 BCL9 CHRNA5 SYNGAP1 MAGI2 NGFR NAV1 MED12 CACNA1C NTRK2 NTRK3 MPZL1 PSD3 GRIN2A IDE | 5.55e-05 | 883 | 226 | 19 | C0036341 |
| Disease | Neurodevelopmental Disorders | 8.26e-05 | 93 | 226 | 6 | C1535926 | |
| Disease | depressive symptom measurement | ZHX3 HIVEP1 ZMYND8 MED12 TCF20 UBE3B PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ASXL3 | 1.21e-04 | 426 | 226 | 12 | EFO_0007006 |
| Disease | post-traumatic stress disorder | 1.75e-04 | 202 | 226 | 8 | EFO_0001358 | |
| Disease | Disorder of eye | 2.43e-04 | 212 | 226 | 8 | C0015397 | |
| Disease | uveal melanoma (is_implicated_in) | 3.47e-04 | 4 | 226 | 2 | DOID:6039 (is_implicated_in) | |
| Disease | hydantoin-5-propionate measurement | 3.47e-04 | 4 | 226 | 2 | EFO_0800051 | |
| Disease | blood metabolite measurement | 3.92e-04 | 19 | 226 | 3 | EFO_0005664 | |
| Disease | selective IgA deficiency disease | 4.25e-04 | 46 | 226 | 4 | EFO_1001929 | |
| Disease | Malignant Cystosarcoma Phyllodes | 5.75e-04 | 5 | 226 | 2 | C0600066 | |
| Disease | Epidermolysis Bullosa Simplex | 5.75e-04 | 5 | 226 | 2 | C0079298 | |
| Disease | Phyllodes Tumor | 5.75e-04 | 5 | 226 | 2 | C0010701 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 5.75e-04 | 5 | 226 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Hypoplastic Left Heart Syndrome | 5.75e-04 | 5 | 226 | 2 | C0152101 | |
| Disease | Major Depressive Disorder | 6.03e-04 | 243 | 226 | 8 | C1269683 | |
| Disease | Alzheimer disease, polygenic risk score | ZFP3 ZNF366 GJD4 DST TCF20 PSD3 MUC19 TACC2 ECHDC3 KANSL1 GOLPH3L HYDIN MTSS2 | 6.36e-04 | 586 | 226 | 13 | EFO_0030082, MONDO_0004975 |
| Disease | smoking status measurement | WBP1L ZNF207 PHF21A SYNGAP1 MAGI2 ALMS1 PTPRF UNC79 WDR24 BRWD1 ZNF438 CACNA1C TCF20 LMTK2 GRIN2A SPTBN4 TRAP1 KANSL1 SETBP1 PLXNA4 | 6.51e-04 | 1160 | 226 | 20 | EFO_0006527 |
| Disease | severe acute respiratory syndrome, COVID-19 | CWC27 NFASC CRLF2 MAGI2 HCG22 TBL1X ARHGEF28 NTRK2 PSD3 PCDHA6 PALM | 7.16e-04 | 447 | 226 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Intellectual Disability | AHI1 MAP1B PHF21A SYNGAP1 KMT2C TCF20 NSD2 SETD2 KANSL1 AASS SETBP1 | 7.16e-04 | 447 | 226 | 11 | C3714756 |
| Disease | bipolar I disorder | 7.84e-04 | 141 | 226 | 6 | EFO_0009963 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 8.58e-04 | 6 | 226 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Unipolar Depression | 9.12e-04 | 259 | 226 | 8 | C0041696 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.01e-03 | 148 | 226 | 6 | C0279702 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 1.03e-03 | 58 | 226 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.24e-03 | 61 | 226 | 4 | C1961102 | |
| Disease | stimulant use measurement | 1.26e-03 | 28 | 226 | 3 | EFO_0600076 | |
| Disease | unipolar depression, bipolar disorder | 1.32e-03 | 156 | 226 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | HIVEP1 CDH23 NFASC PHF21A MAGI2 ALMS1 PTPRF UNC79 BRWD1 TCF20 NTRK3 TACC2 GRIN2A SETBP1 PLXNA4 | 1.39e-03 | 801 | 226 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | respiratory failure, COVID-19 | 1.40e-03 | 29 | 226 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Malignant mesothelioma | 1.54e-03 | 109 | 226 | 5 | C0345967 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 1.59e-03 | 8 | 226 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | NEPHRONOPHTHISIS 2 | 1.59e-03 | 8 | 226 | 2 | C1865872 | |
| Disease | Malignant neoplasm of breast | ZNF366 BAP1 BRCA2 MED12 ZNF438 NID2 ANK2 NSD2 TACC2 SETD2 TRAPPC12 SETBP1 SNAI2 MAP3K13 SPEN ENPEP LRRFIP1 ZNF646 | 1.65e-03 | 1074 | 226 | 18 | C0006142 |
| Disease | Nephronophthisis | 2.03e-03 | 9 | 226 | 2 | cv:C0687120 | |
| Disease | Malignant Glioma | 2.07e-03 | 70 | 226 | 4 | C0555198 | |
| Disease | mixed gliomas | 2.07e-03 | 70 | 226 | 4 | C0259783 | |
| Disease | Manic Disorder | 2.18e-03 | 71 | 226 | 4 | C0024713 | |
| Disease | risk-taking behaviour | HIVEP1 CDH23 NFASC PHF21A MAGI2 PTPRF UNC79 CACNA1C TCF20 NTRK2 NTRK3 GRIN2A SENP7 MTSS2 | 2.43e-03 | 764 | 226 | 14 | EFO_0008579 |
| Disease | Prostatic Neoplasms | UNC13D CASZ1 BAP1 KMT2C BRCA2 NGFR MED12 LMTK2 SETD2 TMF1 AKAP13 SPEN | 3.00e-03 | 616 | 226 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | UNC13D CASZ1 BAP1 KMT2C BRCA2 NGFR MED12 LMTK2 SETD2 TMF1 AKAP13 SPEN | 3.00e-03 | 616 | 226 | 12 | C0376358 |
| Disease | Semantic-Pragmatic Disorder | 3.07e-03 | 11 | 226 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 3.07e-03 | 11 | 226 | 2 | C0751257 | |
| Disease | Language Delay | 3.07e-03 | 11 | 226 | 2 | C0023012 | |
| Disease | Language Development Disorders | 3.07e-03 | 11 | 226 | 2 | C0023014 | |
| Disease | Speech Delay | 3.07e-03 | 11 | 226 | 2 | C0241210 | |
| Disease | Manic | 3.07e-03 | 78 | 226 | 4 | C0338831 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.11e-03 | 128 | 226 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.11e-03 | 128 | 226 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.11e-03 | 128 | 226 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.11e-03 | 128 | 226 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.11e-03 | 128 | 226 | 5 | C0007134 | |
| Disease | melanoma | 3.13e-03 | 248 | 226 | 7 | C0025202 | |
| Disease | Depression, Bipolar | 3.21e-03 | 79 | 226 | 4 | C0005587 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.46e-03 | 189 | 226 | 6 | EFO_0009932 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 3.66e-03 | 12 | 226 | 2 | C0403553 | |
| Disease | Ischemic stroke | 3.67e-03 | 324 | 226 | 8 | HP_0002140 | |
| Disease | sensory perception of sweet taste | 3.68e-03 | 82 | 226 | 4 | GO_0050916 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.81e-03 | 41 | 226 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.81e-03 | 41 | 226 | 3 | C0858252 | |
| Disease | response to anticoagulant | 3.81e-03 | 41 | 226 | 3 | GO_0061476 | |
| Disease | beverage consumption measurement | 3.84e-03 | 83 | 226 | 4 | EFO_0010088 | |
| Disease | autism spectrum disorder, schizophrenia | 3.88e-03 | 327 | 226 | 8 | EFO_0003756, MONDO_0005090 | |
| Disease | survival time, breast carcinoma | 4.31e-03 | 13 | 226 | 2 | EFO_0000305, EFO_0000714 | |
| Disease | Paraganglioma | 4.31e-03 | 13 | 226 | 2 | C0030421 | |
| Disease | sphingomyelin 18:1 measurement | 4.31e-03 | 13 | 226 | 2 | EFO_0010394 | |
| Disease | N-acetylglutamine measurement | 4.31e-03 | 13 | 226 | 2 | EFO_0800017 | |
| Disease | Nephronophthisis | 4.31e-03 | 13 | 226 | 2 | C0687120 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 4.37e-03 | 43 | 226 | 3 | DOID:9261 (is_marker_for) | |
| Disease | monocyte percentage of leukocytes | AHI1 ARID4B WBP1L CDH23 TNFRSF10B RASA2 UBE3B ANKRD44 SETD2 TRAP1 KANSL1 MAP1S AKAP13 | 4.41e-03 | 731 | 226 | 13 | EFO_0007989 |
| Disease | Glioma | 4.54e-03 | 87 | 226 | 4 | C0017638 | |
| Disease | Anxiety States, Neurotic | 4.66e-03 | 44 | 226 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 4.66e-03 | 44 | 226 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 4.66e-03 | 44 | 226 | 3 | C0003469 | |
| Disease | carpal tunnel syndrome | 4.92e-03 | 89 | 226 | 4 | EFO_0004143 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 5.00e-03 | 14 | 226 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | 1-methylurate measurement | 5.00e-03 | 14 | 226 | 2 | EFO_0021173 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 5.00e-03 | 14 | 226 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 5.00e-03 | 14 | 226 | 2 | DOID:7474 (is_marker_for) | |
| Disease | Sclerocystic Ovaries | 5.13e-03 | 144 | 226 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 5.13e-03 | 144 | 226 | 5 | C0032460 | |
| Disease | asthma | AHI1 RAPGEF6 HIVEP1 ARID4B IP6K3 SUSD6 WBP1L UNC13D SARDH UNC79 IKZF3 TRAP1 SENP7 | 5.50e-03 | 751 | 226 | 13 | MONDO_0004979 |
| Disease | cryptic phenotype measurement | 5.61e-03 | 47 | 226 | 3 | EFO_0021487 | |
| Disease | Salivary Gland Neoplasms | 5.61e-03 | 47 | 226 | 3 | C0036095 | |
| Disease | Tinnitus, response to cisplatin | 5.74e-03 | 15 | 226 | 2 | GO_0072718, HP_0000360 | |
| Disease | response to olanzapine | 5.74e-03 | 15 | 226 | 2 | GO_0097333 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.30e-03 | 49 | 226 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Congenital total cataract | 6.53e-03 | 16 | 226 | 2 | C0266539 | |
| Disease | lung small cell carcinoma (is_marker_for) | 6.53e-03 | 16 | 226 | 2 | DOID:5409 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKESKDILAPHIGSD | 591 | Q9BXU7 | |
| LAHTGSVETLPSEES | 81 | Q8NBF4 | |
| SSTVEVQDDHIKGPL | 46 | Q4LE39 | |
| HLGSSAPGKEKSETD | 721 | Q5SW79 | |
| SAHPSLEVSEDGKSV | 336 | Q6UXG8 | |
| SAAKLGIHPSDSEGE | 486 | O94986 | |
| LDPKEAEHLGTSSSL | 801 | A0A096LP49 | |
| HLKTFSISESPLEGT | 631 | Q8IVF6 | |
| HLSSVPVVESEKGDA | 241 | Q6UX04 | |
| STTFVSDGSLEKHPE | 2456 | P13611 | |
| AGESIASSHVKAPED | 536 | Q68DQ2 | |
| LSEHQVTSSGDKDRP | 961 | P42684 | |
| LPHIKETTSDDVSAA | 71 | Q8N157 | |
| FEKLHAGSTPEAATS | 206 | Q86V15 | |
| GKLHFGIDPDDTTIT | 291 | Q7L266 | |
| SEAKTEEPTVHSSEA | 181 | Q96G28 | |
| DLVGISPSSEHDVLK | 766 | Q9UDR5 | |
| VPETLDSGALHSEKA | 1896 | O00468 | |
| AGASDVHVTSKPVDK | 516 | Q12802 | |
| SHPTEEALKISVASE | 1351 | Q8TCU4 | |
| LPGSHLTEEAKNVSA | 1396 | Q8TCU4 | |
| IIETPHKEIGTSDFS | 71 | O96020 | |
| FHSPLDAGATSEIKT | 816 | Q8IYW2 | |
| SPVTSHISKVLFGED | 521 | Q92560 | |
| VEDEGTPTLSATTHV | 1606 | Q9H251 | |
| THEPGEEASLKGTLD | 526 | O95905 | |
| EHVPENSKTGTALEI | 176 | Q96BY7 | |
| TEHKESETAVETSTP | 556 | Q9C0F0 | |
| SVVTSEPDKHSLLVG | 1476 | Q04656 | |
| SIEPKATETSHTEGI | 556 | Q7Z5L2 | |
| SVEPDDHLTVAESLK | 371 | O95199 | |
| ETADITHALSKLTEP | 356 | Q15042 | |
| EVEGPLLSDTHVTFK | 356 | P49116 | |
| PLSSSEVDELIHKAD | 226 | O75781 | |
| VKDHGEPALTATATV | 651 | Q9Y5H5 | |
| ESSGTSEPVHLKEGE | 596 | Q15283 | |
| HGSDSESEETRKLPG | 116 | Q96ST2 | |
| IHGESPTSSATLKDL | 61 | H3BPF8 | |
| TPLDDGASKLDDLHT | 441 | Q9HD26 | |
| VKDHGEPALTATATV | 651 | Q9Y5H9 | |
| VKDHGEPALTATATV | 651 | Q9UN73 | |
| DHVAVLGSPLAASKE | 271 | Q9H8H0 | |
| DSVLADTLSSHDVPG | 1306 | Q8N1W1 | |
| VSHKDSLEASPVLED | 2431 | Q01484 | |
| VKDHGEPSLTATATV | 651 | Q9UN72 | |
| IHLSISDEADSTIPK | 436 | Q9P260 | |
| EESSEGSKTHTPLLD | 346 | Q5TGI0 | |
| KDHGEPALTATATVL | 651 | Q9Y5I1 | |
| SSTHPEDTDKIGAVL | 276 | Q8NH92 | |
| VKDHGEPALTATATV | 651 | Q9Y5H6 | |
| VKDHGEPSLTATATV | 651 | Q9Y5H8 | |
| RGSEEPTLKHEATSE | 1656 | Q7RTP6 | |
| DLAKSVDHSDIGPVT | 1451 | Q8NEZ4 | |
| TTDDVSPSLHAEVGS | 1566 | P46821 | |
| VGSPHSTEVDESLSV | 686 | Q66K74 | |
| DDSVEADKSSPGIHL | 496 | Q14676 | |
| GVVVTPESSEHEDKS | 246 | Q86UL8 | |
| TIAPGKTHTAAIDER | 601 | Q8TD19 | |
| SIAGTIKTEGEHDPV | 561 | Q8IXH7 | |
| SSLLTSHEPEEVTKG | 456 | Q9NPP4 | |
| ALVTPDSEKSAKHGS | 186 | Q96EK9 | |
| AGPSEAESTHLDTKK | 286 | Q9NQ76 | |
| DTDDHKTDNTGTLPE | 106 | A8MXV4 | |
| VTHKPEEDTFGVSIA | 421 | Q16288 | |
| LFSVKSSLSHGPKEE | 601 | Q86W26 | |
| DTESEKTFGPASISH | 2716 | Q03001 | |
| AGEPITDDSTSLHKF | 31 | Q9BQS8 | |
| ETHEALSFLPGLKDS | 1191 | A6NM62 | |
| TPGVAADLSHIETKA | 61 | P40926 | |
| TKEDHETPSSAELVA | 16 | Q8N4Q1 | |
| LAGEKESPSSVADDH | 1246 | Q2LD37 | |
| TSRVSGHTKIPDEDE | 281 | Q96KN9 | |
| GHTKIPDEDESEVTS | 286 | Q96KN9 | |
| PVFSSGHDLKELTEE | 101 | Q96DC8 | |
| EIPTVESETHLGTSD | 1011 | Q9P2D6 | |
| ESILSEHEESPKAGT | 411 | Q96RV3 | |
| SDLKVLVTHETGPDE | 76 | Q9HCM2 | |
| KPDADIDTTHLSVDV | 676 | Q96KP1 | |
| IDTTHLSVDVSSPDL | 681 | Q96KP1 | |
| TIAAKHGEEVSPAAS | 431 | Q765P7 | |
| KVLEPGSAHTEATTF | 7331 | Q7Z5P9 | |
| QLGTKDEDPHTSDLV | 491 | O95263 | |
| CSSAETLESHPDIGK | 406 | O96028 | |
| GIVSLKLEDDSFPTH | 1951 | Q5H8C1 | |
| HGIDLSKPVDSEATV | 626 | Q96BD5 | |
| DPADLTHDTTGLTAK | 106 | Q9UMX5 | |
| LPLSSEVKTDHGTDK | 496 | Q7Z3B3 | |
| HESSSSDEERAAAKP | 596 | Q14693 | |
| EPTTEIGHSTALEKT | 456 | Q96QE4 | |
| TDPKDSSLPGDLHVT | 611 | Q8IWU2 | |
| HKEAEGSSSSKLEDP | 646 | Q93074 | |
| SIVATDHEPTDARKS | 216 | Q07075 | |
| FEEIAKISHESPGSS | 36 | Q96N21 | |
| ESDSGATKSPLHLAA | 561 | Q8N8A2 | |
| EDKADPGHSEISSTR | 316 | Q6WN34 | |
| TEEKEASGGSLQLPH | 331 | Q9HC73 | |
| SDTEGLVKSLPSGSH | 221 | O95297 | |
| ITSVPLDSEKSDDHV | 1166 | A7KAX9 | |
| DSESEAHLLDSKVPS | 1166 | P16144 | |
| DSTGHLSLVANPVKE | 76 | Q96PC2 | |
| NKHIEDTGSTPSIGE | 1166 | Q6R327 | |
| QEGTPSASTKHILDD | 1171 | Q8WXE0 | |
| SDVTLLKIGSEEPHF | 821 | Q8IZQ8 | |
| SSVPDLTHGEEDIGK | 851 | Q9NYA4 | |
| TLSDSKHVVLPVDDD | 136 | Q15291 | |
| VSISVHSEKSDGPFR | 416 | Q7Z6E9 | |
| SSTHPEDTDKIGAVL | 276 | Q8NGQ3 | |
| EDSVTADPGTTKHSI | 206 | E2RYF7 | |
| VTADPGTTEDETTKH | 231 | E2RYF7 | |
| VKDHGEPALTATATV | 651 | Q9Y5I3 | |
| VKDHGEPALTATATV | 651 | Q9Y5I0 | |
| KDHGEPSLTATATVL | 651 | Q9Y5I2 | |
| GHTESKDDPSLIEGL | 226 | Q9UII4 | |
| PIDISSHSDGLSDKE | 896 | O43283 | |
| EESSTLDPHTKEGTS | 356 | Q14112 | |
| VKDHGEPALTATATV | 651 | Q9UN74 | |
| SGTKIHESAPDEQSI | 1106 | O94856 | |
| SSHTSGIEADTKPRD | 391 | Q96NE9 | |
| GLSEPSSIAKHEDSL | 36 | P30532 | |
| ALPAGLSATEKADAH | 226 | Q567U6 | |
| SAEESPEKLGTSQLH | 301 | Q567U6 | |
| GSVVTDSIHATDPDT | 496 | Q9BYE9 | |
| LEDSLSSGHKEEELP | 881 | Q711Q0 | |
| SVEVLFEPSHLGETK | 4986 | Q4G0P3 | |
| SVIPETSEGESSDHT | 676 | Q5SW24 | |
| GDTESPSHEKLVDST | 1786 | Q13936 | |
| PSTKAELEEKGHSAT | 571 | Q14185 | |
| EDDELTDSKLPSHAT | 2236 | P51587 | |
| ESEGAKVIEVSLPHT | 306 | Q9H0R6 | |
| HDAIKTVASSDDDSP | 1026 | O00512 | |
| HIIPKGKDEETASSS | 1556 | Q8N3K9 | |
| FSLKGLSEEVSHPAD | 1746 | Q8N3K9 | |
| ILDKLSEETGHPNSS | 1786 | Q8N3K9 | |
| SGATHVQETSLEEPK | 3386 | Q8N3K9 | |
| DSPTGDVLLDETLKH | 111 | Q9H4A5 | |
| DHLSGVPTDVTVTET | 256 | Q9BSJ5 | |
| SHPELENVKISETTG | 2131 | Q9NSI6 | |
| AHSVPKGKTATEAAD | 191 | Q96NU7 | |
| KPSEHKAVDTSDLGI | 371 | Q9UH90 | |
| LEVPESHTASELKLG | 1586 | Q9Y4F3 | |
| PESLKDGIFTTHSDV | 1161 | P14616 | |
| AIPSGKETSIELDVH | 206 | Q96J84 | |
| SAHPESTTVEEDISK | 1101 | Q9ULL0 | |
| GEEKLSLEAHAGSPS | 711 | Q76NI1 | |
| GETFTCTAAHPELKT | 186 | P01877 | |
| PTTDKSSAALDVHIG | 81 | P14735 | |
| ETSPVIHLVTDAKGT | 316 | Q66K89 | |
| TDSSHDPQEEKAVSG | 356 | Q15007 | |
| TDPGDTASAEARHIK | 231 | Q9UKT9 | |
| GELDSAHSLLTKTPD | 106 | Q9NZ56 | |
| ESVGGSPQTKHLIED | 151 | Q08495 | |
| TDSPTVHLGLDSDSE | 696 | Q9ULU4 | |
| DTDVAVSTPASKHGL | 396 | Q5SV97 | |
| DPGHSSSVKELDTDA | 46 | Q9C0B2 | |
| GFLHASSSIESEAKP | 196 | Q14154 | |
| PQELETSTGHSLEKE | 461 | Q32MZ4 | |
| DPADSTTTHKESAGK | 141 | Q3MIW9 | |
| GLKDSLLAHSSDPVE | 1301 | P10586 | |
| VKDHGEPALTSTATV | 651 | Q9UN75 | |
| HPSVKDDSDLEGRTS | 311 | Q9Y283 | |
| DPTDDVHGSVLSLAS | 1051 | Q8NEY1 | |
| DSDDKSLSFVLHSGP | 1336 | P0C091 | |
| KASDHEGLLSDPLSD | 926 | Q6WKZ4 | |
| VVSSDEEGPVEHKSS | 441 | Q9BQF6 | |
| AEIVPVTTTVHDDKG | 221 | P09110 | |
| HLGSSSVALPKEASD | 131 | Q8NFQ8 | |
| PESTGALEKTEHASG | 1301 | Q8TEU7 | |
| HSSSELSPDAVEKAG | 1381 | Q9UQ35 | |
| KDSPHLDAITATESA | 1916 | B5MCY1 | |
| HSEGTLDINGVTPKE | 476 | Q9H3W5 | |
| LHIESSDEKSPSDVS | 591 | O14513 | |
| TSKAKIIDHSGDPAE | 421 | Q7Z494 | |
| VEEVHDDGTPTSKTF | 141 | P51665 | |
| ESGAESQSDIHTRKP | 161 | Q53T94 | |
| DSEVEASLGIPHSSS | 286 | O94933 | |
| SKDHSGSESPISDEE | 96 | O43623 | |
| GSILEDATPTATKHG | 561 | O60292 | |
| ASSGCEITLPHTEKA | 101 | Q8IUQ4 | |
| GKSSEPSTSLGELEH | 131 | Q9Y6H5 | |
| SDLKHITSEADSDPG | 1021 | Q562F6 | |
| TDGDSFHPLITKDEV | 251 | Q14108 | |
| ASLTPVKSGEHKDED | 906 | Q9UPS6 | |
| GEEKDGAAVSLSTPH | 86 | Q66K80 | |
| PHTLDLSEGSAESKL | 3141 | Q9P2P6 | |
| SESPLGDLVSTHKLA | 451 | Q9BZV3 | |
| KEGHFPRVTTVSDLT | 81 | Q9P1W8 | |
| EDKDTHTSLGVPTLS | 106 | Q92537 | |
| HSSEPRVADIKEESS | 291 | Q8N1H7 | |
| GVESHVLSPAETKTL | 176 | Q9UL12 | |
| GHSVPEINSDTDKSE | 346 | Q9UEE5 | |
| IDKAEHEISSSPGSL | 756 | Q8IZF2 | |
| EIPSTDVTDKTGREH | 416 | Q16620 | |
| PSSKATVLRGHESEV | 221 | O60907 | |
| PHAFKTESGEETDLI | 291 | O43493 | |
| AGTSSPKTEGKHEET | 166 | P82094 | |
| AISHSDKGPDATAIS | 86 | Q86TZ1 | |
| SGHLAKETRVSPEEA | 66 | Q9NS28 | |
| LAVKLTSGDSESHPE | 221 | Q99973 | |
| KPHVDLGEFIGSSET | 656 | O75970 | |
| SETSHSVPEAKGSKE | 2306 | Q96T58 | |
| HIEEPKVLSEAGSAA | 1391 | Q13129 | |
| DEDSIIKPVHSSILG | 201 | Q96PV0 | |
| ASEGSSPLADKLNEH | 51 | Q8WVT3 | |
| PEGEKLHSDSGISVD | 296 | P08138 | |
| PEEEIDHTGAKTKSA | 546 | O95757 | |
| PGDLVIVEKDHSATT | 806 | Q6IQ55 | |
| PHALVLKEVTEASTG | 381 | P35916 | |
| KEATPHLQGETVSTD | 111 | O15015 | |
| AETTHKEEEDPTTTL | 446 | O15015 | |
| GDKEHVSPIATEKAS | 631 | Q8TBZ2 | |
| GEPLLSLHKATSEVA | 2471 | Q9H254 | |
| LHEETTIPGTDLKLS | 991 | Q9P273 | |
| VPEEDALSSKEHSES | 726 | Q96N46 | |
| DGAKVHEDSTSPAVA | 551 | O95359 | |
| HEDSTSPAVAKEGSR | 556 | O95359 | |
| GAHLEEKKTPESSLS | 581 | Q2M1Z3 | |
| KESGTKHSGEVPAVE | 181 | O14763 | |
| KHSGEVPAVEETVTS | 186 | O14763 | |
| KTETHAETVTAGKEP | 1446 | Q9UGU0 | |
| DGVDSTSHTDVKSDP | 1166 | Q9BYW2 | |
| HKEVVDGSPAAASTI | 716 | O15195 | |
| TTSATSKLIHPDEDI | 356 | O43670 | |
| EKLGLVETSSASPHV | 666 | Q7Z3V4 | |
| EAVPSGDTQESLHIK | 36 | O95201 | |
| EDLSTKSEHAPEVLE | 646 | Q8N895 | |
| DKEEPLHSIISSTES | 66 | Q12931 | |
| ESAASHEAKKTGPTI | 136 | Q86YA3 | |
| GEASPLSSLTEEAHD | 11 | Q5T619 | |
| ESPHTSEFKGAALVS | 21 | Q6XPS3 | |
| DSPIHSSASTLEKIG | 886 | Q70CQ4 | |
| KADSPHVSGSEADVA | 591 | Q96S15 | |
| ASLVTEPTKHGETVA | 701 | Q5JPB2 | |
| LERDKGHGSPSTSEV | 631 | Q5H8A4 | |
| VGVATLKLTDVHPSD | 101 | Q96IQ7 | |
| LDSVHKSTDSGPSEL | 531 | Q6ZS17 | |
| GSLKEITLSPVSESH | 846 | Q9Y6X0 | |
| VSESHSEETIPSDSG | 856 | Q9Y6X0 | |
| GDHSSIIIDSVPEVS | 561 | Q9H4I2 | |
| ERGKPEKVHSSSEES | 706 | Q7Z4V0 | |
| HSGLDSVTEGPKDVR | 101 | Q9NYI0 | |
| ELVPLGELTKHSTSA | 616 | Q70J99 | |
| ELLKDDSSEHGAPDS | 221 | Q9NX94 | |
| SHESPKALSIHSDVE | 476 | P15822 | |
| KEEISEESEPHGSLL | 11 | Q96NJ6 | |
| SGPEKHSILSTSDSD | 1616 | Q9P2D8 | |
| FTLKDKGSPHSETSE | 1191 | Q12879 |